Filed by the Registrant ☒Filed by a Party other than the Registrant ☐ | ||
Check the appropriate box: | ||
☐ | Preliminary Proxy Statement | |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
☒ | Definitive Proxy Statement | |
☐ | Definitive Additional Materials | |
☐ | Soliciting Material Under §240.14a-12 | |

Payment of Filing Fee (Check all boxes that apply): | ||||
☒ | No fee required. | |||
☐ | Fee paid previously with preliminary materials. | |||
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. | |||


Date and Time Thursday, May 29, 2025 9:00 a.m. EDT | Access Our Annual Meeting can be accessed virtually at: www.virtualshareholder meeting.com/CG2025 | Record Date April 4, 2025 | |||||
How to Vote Vote by Internet Before The Meeting: www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Daylight Time on May 28, 2025. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During the Meeting: www.virtualshareholdermeeting.com/ CG2025 You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. Vote by Phone 1-800-690-6903 By telephone transmit your voting instructions up until 11:59 p.m. Eastern Daylight Time on May 28, 2025. Have your proxy card in hand when you call and then follow the instructions. Vote by Mail Mark, sign, and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. | |||||||
Items of Business | Board Recommendation | ||||||
1 | Election to our Board of Directors of eight director nominees named in this Proxy Statement for a one-year term | FOR ![]() each director nominee | |||||
2 | Ratification of Ernst & Young LLP (“Ernst & Young”) as Our Independent Registered Public Accounting Firm for 2025 | FOR ![]() | |||||
3 | Non-Binding Vote to Approve Named Executive Officer Compensation (“Say-on-Pay”) | FOR ![]() | |||||
Transaction of such other business as may properly come before our 2025 Annual Meeting of Shareholders Your vote is important to us. Please exercise your shareholder right to vote. By Order of the Board of Directors, ANNE K. FREDERICK Corporate Secretary April 17, 2025 | |||||||
Important Notice Regarding the Availability of Proxy Materials for our Annual Meeting to be held on Thursday, May 29, 2025. Our Proxy Statement and 2024 Annual Report to Shareholders are available at www.proxyvote.com. On or about April 17, 2025, we will distribute the proxy materials and send to certain of our shareholders a Notice of Internet Availability of Proxy Materials (“Notice”). The Notice includes instructions on how to access our Proxy Statement and 2024 Annual Report to Shareholders and vote online. For more information, see “Frequently Asked Questions.” |
This Proxy Statement may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, statements related to our expectations, estimates, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions and statements that are not historical facts, including our expectations regarding the performance of our business, our financial results, our liquidity and capital resources, contingencies, and our dividend policy. You can identify these forward-looking statements by the use of words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates,” or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks, uncertainties, and assumptions. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements including, but not limited to, those described in this Proxy Statement and under the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (“SEC”) on February 27, 2025, as such factors may be updated from time to time in our periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this proxy statement and in our periodic filings with the SEC. We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise, except as required by applicable law. |
CARLYLE | Proxy Statement 2025 | 1 |
On behalf of the Board and the entire Carlyle team, thank you for your support. We look forward to continued dialogue with you in various forums during the year. |
![]() | |
HARVEY M. SCHWARTZ | |
Chief Executive Officer and Director | |
April 17, 2025 |
![]() | |
MARK S. ORDAN | |
Lead Independent Director | |
April 17, 2025 |
2 | CARLYLE | Proxy Statement 2025 |
Proposal | Board Recommendation | Page Reference | ||
Item 1 | Election to our Board of Directors of eight director nominees named in this Proxy Statement for a one-year term The Board believes that each of the director nominees has the knowledge, experience, skills, and background necessary to contribute to an effective and well-functioning Board. | ![]() | FOR each director nominee | |
Item 2 | Ratification of Ernst & Young as Our Independent Registered Public Accounting Firm for 2025 The Audit Committee has appointed Ernst & Young to serve as Carlyle’s independent registered public accounting firm for the 2025 calendar year and this appointment is being submitted to our shareholders for ratification. The Audit Committee believes that the continued retention of Ernst & Young to serve as Carlyle’s independent auditor is in the best interests of Carlyle and its shareholders. | ![]() | FOR | |
Item 3 | Non-Binding Vote to Approve Named Executive Officer (“NEOs”) Compensation (“Say-on-Pay”) Carlyle seeks approval from its shareholders, in a non-binding advisory vote, of the compensation of the NEOs as disclosed in this Proxy Statement. The Board values the opinions of our shareholders and will take into account the outcome of the advisory vote when considering future executive compensation decisions. | ![]() | FOR | |
CARLYLE | Proxy Statement 2025 | 3 |
Executive Summary |


4 | CARLYLE | Proxy Statement 2025 |
Executive Summary |

Our Board advises management and provides oversight ![]() of the firm’s business and affairs Our Board has a broad range of skills, experiences, ![]() and perspectives The Board has a strong, newly appointed Lead ![]() Independent Director, Mark S. Ordan, who works closely with the other independent directors to provide objective oversight of our business and facilitates communication with the Board, the identification of matters for consideration by the Board and management, and the formulation of appropriate guidance to be provided by the independent directors to our leadership team The independent members of the Board meet in ![]() executive session regularly without the presence of management. The Board's Lead Independent Director presides over these executive sessions The Nominating and Corporate Governance ![]() Committee leads the annual Board, Committee, and director assessments Our Board is in the process of being declassified on a ![]() phased-in basis and the Board will be fully declassified by the 2026 Annual Meeting of Shareholders Our executive officers and heads of our business ![]() segments are subject to clawback policies (our Incentive Compensation Clawback Policy and/or our Dodd-Frank Incentive Compensation Clawback Policy) | Our directors and executive officers are required to hold ![]() shares of our common stock with a minimum value determined based on their respective position We prohibit short sales and derivative transactions in our ![]() equity and hedging our common stock, and generally prohibit pledging of our stock absent prior approval The full Board focuses on succession planning ![]() On an ongoing basis, the Board, led by the Nominating ![]() and Corporate Governance Committee, considers the composition of the Board as a whole, and seeks to identify potential directors who have the necessary skills, experience and personal attributes to advise management and effectively oversee the Company The Board receives regular updates on our ![]() sustainability strategy The Nominating and Corporate Governance Committee, ![]() which takes a leadership role in shaping our corporate governance, including oversight of and approach to our sustainability strategy has appointed Linda H. Filler as the Board’s Sustainability Lead, responsible for oversight of the firm’s work in this area The Audit Committee takes a leadership role in the ![]() review and oversight of technology and information security risks, including cybersecurity |
CARLYLE | Proxy Statement 2025 | 5 |
Executive Summary |
Form | Compensation Element | CEO | Other NEOs | Purpose and Alignment |
Cash | Base Salary | ![]() | ![]() | Provides a base compensation floor for our executives. |
Annual Performance Bonus | ![]() | ![]() | Rewards achievement of key strategic and financial priorities and goals. | |
Long- Term Equity Awards | Time-Vesting Restricted Stock Units | ![]() | ![]() | Restricted Stock Units (“RSUs”) awarded to our NEOs that are generally eligible to vest over 3.5 to 4 years in order to promote continued retention and share ownership. |
Performance-Vesting Restricted Stock Units (Stock Price Performance) | ![]() | ![]() | Grants to Mr. Schwartz and certain of our other NEOs in order to align the interests of our NEOs with those of our shareholders and drive stock price appreciation. Mr. Schwartz’s 2023 performance-vesting RSU (“PSU”) award also encourages strong relative performance, with 110% stock price appreciation and superior outperformance relative to the constituent companies in the S&P 500 Financials Index required for full vesting. |
WHAT WE DO: | |
Align pay with firm performance and shareholder ![]() interests, including through use of RSUs and PSUs Large majority of compensation is variable, and the ![]() majority is delivered in equity Long-term incentive awards are denominated and ![]() settled in equity Regularly engage with shareholders as part of our ![]() year-round, proactive engagement Engage an independent compensation consultant that ![]() works directly for our Compensation Committee and does no work for management Tie incentive compensation to a clawback policy that ![]() cover financial restatements, with one policy extending beyond the mandates of the Dodd-Frank Act and including recoupment upon detrimental activity | Require our executive officers to own a minimum value ![]() of shares of our common stock and retain a portion of certain RSU and PSU awards for a fixed minimum period following vesting Hold an annual Say-on-Pay vote and disclose response ![]() to shareholder feedback Perform an annual compensation risk assessment ![]() For our CEO’s Sign-On PSU Award, full vesting requires ![]() both 110% stock price appreciation over the 5-year performance period and relative TSR performance at the 60th percentile versus S&P 500 Financials Index constituent companies Require a qualifying termination of employment following ![]() a change in control of Carlyle in order for any such change in control to trigger accelerated vesting rights |
WHAT WE DO NOT DO: | |
No excise tax “gross-up” payments in the event of a ![]() change in control No tax “gross-up” payment in perquisites for named ![]() executive officers No defined benefit plan pension benefits for ![]() executive officers No short sales or derivative transactions in our equity or ![]() hedging our common stock, and we generally prohibit pledging of our stock absent prior approval | No dividends paid in cash on unvested equity awards ![]() Do not count unvested PSUs or unexercised ![]() stock options toward satisfaction of stock ownership guidelines No repricing of underwater stock options ![]() No changes to performance targets for legacy ![]() performance-vesting awards |
6 | CARLYLE | Proxy Statement 2025 |
Item 1 | Election of Directors | ||
Our Board of Directors currently is composed of thirteen directors. A majority our directors are independent, and five are employees or consultants of the firm in addition to serving as directors. Our independent directors are composed of highly educated professionals with a broad range of experience in different industries that helps to inform our global investment management business, including banking and finance, accounting, healthcare, pharmaceuticals, real estate, hospitality, consumer products, telecommunications, marketing, and education. The directors who are not independent have extensive experience and strong reputations within the global investment management industry. In accordance with our amended and restated certificate of incorporation, our Board is in the process of being declassified on a phased-in basis and will be fully declassified by the 2026 Annual Meeting of Shareholders. Each director nominee, if elected, will serve for a one-year term. A director’s term continues until the election and qualification of his or her successor or his or her earlier death, resignation, or removal. The Board believes that each of the director nominees has the knowledge, experience, skills, and background necessary to contribute to an effective and well-functioning Board. In connection with our conversion from a Delaware limited partnership into a Delaware corporation (the “Conversion”), we entered into stockholder agreements with our co-founders. These agreements grant each of our co-founders the right to designate nominees to our Board subject to the maintenance of certain ownership requirements. See “Certain Relationships and Related Transactions—Stockholder Agreements” for additional information. The Board has selected David M. Rubenstein, Daniel A. D’Aniello, Harvey M. Schwartz, Sharda Cherwoo, Linda H. Filler, James H. Hance, Jr., Derica W. Rice, and William J. Shaw for election as directors at this 2025 Annual Meeting of Shareholders. If elected, each director will serve until the 2026 Annual Meeting of Shareholders, and thereafter until their successors are duly elected and qualified, or until such director’s earlier death, resignation, or removal. | |||
FOR ![]() | BOARD RECOMMENDATION | ||
After a review of the individual qualifications and experiences of each of our director nominees and their contributions to our Board, our Board determined unanimously to recommend that shareholders vote “FOR” the eight director nominees named in this Proxy Statement. | |||
CARLYLE | Proxy Statement 2025 | 7 |
Corporate Governance |
![]() DAVID M. RUBENSTEIN Co-Founder and Co-Chairman of the Board Age: 75 Director Since: 2011 Class: II (expires 2025) | |||
Mr. Rubenstein is a Co-Founder and Co-Chairman of the Board. He was appointed to our Board of Directors effective July 18, 2011. Previously, Mr. Rubenstein served as Co-Chief Executive Officer of Carlyle. Mr. Rubenstein is a Baltimore native and is the Chairman, CEO, and principal owner of Major League Baseball’s Baltimore Orioles. Prior to forming Carlyle in 1987, Mr. Rubenstein practiced law in Washington, D.C. with Shaw, Pittman, Potts & Trowbridge LLP (now Pillsbury Winthrop Shaw Pittman LLP). From 1977 to 1981, Mr. Rubenstein was Deputy Assistant to the President for Domestic Policy. From 1975 to 1976, he served as Chief Counsel to the U.S. Senate Judiciary Committee’s Subcommittee on Constitutional Amendments. From 1973 to 1975, Mr. Rubenstein practiced law in New York with Paul, Weiss, Rifkind, Wharton & Garrison LLP. Mr. Rubenstein has served on the board of Moderna, Inc. since August 2024. Among other philanthropic endeavors, Mr. Rubenstein is Chairman of the Boards of the Council on Foreign Relations, the National Gallery of Art, the Economic Club of Washington, and the University of Chicago; a Trustee of Memorial Sloan-Kettering Cancer Center, Johns Hopkins Medicine, the Institute for Advanced Study, the Brookings Institution, and the World Economic Forum; and a Director of the American Academy of Arts and Sciences. Mr. Rubenstein is a member of the American Philosophical Society, Business Council, Harvard Global Advisory Council, Madison Council of the Library of Congress, Board of Dean’s Advisors of the Business School at Harvard, Advisory Board of the School of Economics and Management at Tsinghua University, and Board of the World Economic Forum Global Shapers Community. Mr. Rubenstein is a magna cum laude graduate of Duke University, where he was elected Phi Beta Kappa. Following Duke, Mr. Rubenstein graduated from the University of Chicago Law School, where he was an editor of the Law Review. | |||
Qualifications: Mr. Rubenstein is a co-founder of our firm and has played an integral role in our firm’s successful growth since its founding in 1987. He also has developed a unique and unparalleled understanding of our business. | Committees: •None Skills and Experience: •Financial Services; Global Perspective; Government, Public Policy, and Regulatory Affairs; Senior Executive and Corporate Governance | ||
8 | CARLYLE | Proxy Statement 2025 |
Corporate Governance |
![]() DANIEL A. D’ANIELLO Co-Founder and Chairman Emeritus Age: 78 Director Since: 2011 Term: 2025 | |||
Mr. D’Aniello is a Co-Founder and Chairman Emeritus of Carlyle. He has served on our Board of Directors since the Board’s inception on July 18, 2011, serving as Chairman from 2012 until January 1, 2018. Prior to forming Carlyle in 1987, Mr. D’Aniello was the Vice President for Finance and Development at Marriott Corporation for eight years. Before joining Marriott, Mr. D’Aniello was a financial officer at PepsiCo, Inc. and Trans World Airlines. Mr. D'Aniello served in the United States Navy from 1968 through 1971 during which time he was a Distinguished Naval Graduate of Officer Candidate School, Newport R.I.; a Supply Officer (LTJG) aboard the USS Wasp (CVS 18); and in 2016, Mr. D'Aniello was awarded the designation of Lone Sailor by the U.S. Navy Memorial Foundation. Mr. D’Aniello is Chairman of the American Enterprise Institute for Public Policy Research; Co-Chairman of the Institute for Veterans and Military Families; Chairman of the Wolf Trap Foundation of the Performing Arts; an Advisor to the John Templeton Foundation; a founding Trustee of the Lumen Institute; and a Lifetime Member of the Board of Trustees of Syracuse University, a member of the Chancellor’s Council and the Corporate Advisory Council to the Martin J. Whitman School of Management. Mr. D’Aniello previously served as chairman and/or director of several private and public companies in which Carlyle had significant investment interests. Mr. D’Aniello is a 1968 magna cum laude graduate of Syracuse University, where he was a member of Beta Gamma Sigma, and a 1974 graduate of the Harvard Business School, where he was a Teagle Foundation Fellow. | |||
Qualifications: Mr. D’Aniello is a co-founder of our firm and has played an integral role in our firm’s successful growth since its founding in 1987. He also has developed a unique and unparalleled understanding of our business. | Committees: •None Skills and Experience: •Accounting and Finance; Brand and Marketing; Financial Services; Global Perspective; Risk Management and Compliance; Senior Executive and Corporate Governance; Sustainability | ||
![]() HARVEY M. SCHWARTZ Chief Executive Officer and Director Age: 61 Director Since: 2023 Class: II (expires 2025) | |||
Mr. Schwartz is the Chief Executive Officer of Carlyle and member of the Board of Directors. He has served in such capacity since February 15, 2023, and is based in New York. Mr. Schwartz formerly worked at Goldman Sachs from 1997 to 2018, with his last position being President and Co-Chief Operating Officer. He also held numerous senior leadership positions including Chief Financial Officer and Global Co-Head of the Securities Division. Mr. Schwartz started his career at J. B. Hanauer & Co., and then moved to First Interregional Equity Corporation. In 1989, he joined Citigroup, where he worked in the firm's credit training program and developed a specialty in structuring commodity derivatives. Mr. Schwartz serves on the board of One Mind, a nonprofit that accelerates collaborative research and advocacy to enable all individuals facing brain health challenges to build healthy, productive lives. Mr. Schwartz previously served on the board of Sofi Technologies, Inc. from May 2021 through November 2024. He is involved in a range of investment and philanthropic endeavors that include a focus on mental health and developing future business leaders, including women and young people seeking a career in finance. Mr. Schwartz earned his BA from Rutgers University, where he is a member of the university’s Board of Governors and its Hall of Distinguished Alumni. He received his MBA from Columbia University. | |||
Qualifications: Mr. Schwartz is a widely respected business builder with extensive leadership experience in a high performing, complex global financial institution. He also is a seasoned operator and has a demonstrated ability to develop high performing talent. | Committees: •None Skills and Experience: •Accounting and Finance; Branding and Marketing; Financial Services; Global Perspective; Government, Public Policy, and Regulatory Affairs; Risk Management and Compliance; Senior Executive and Corporate Governance; Succession Planning and Human Capital Management; Technology and/or Cybersecurity | ||
CARLYLE | Proxy Statement 2025 | 9 |
Corporate Governance |
![]() SHARDA CHERWOO Independent Director Age: 66 Director Since: 2023 Term: 2025 | |||
Ms. Cherwoo was appointed to our Board of Directors effective June 1, 2023, and is a member of the Audit Committee. Ms. Cherwoo spent her entire, nearly 40-year career at Ernst & Young (“EY”), a global accounting firm, with a specialized industry focus on private equity, financial services, health care, and emerging disruptive technologies, across diverse industries. Most recently, she served as EY’s Americas Intelligent Automation Leader and Partner, a role in which she spearheaded and founded the company’s intelligent automation strategy focused on robotic process automation (“RPA”) and artificial intelligence (“AI”), leading to talent development and transformation. She led and built a billion-dollar, market-leading digital transformation business, and worked with global clients and teams across diverse industries in more than 20 countries. During her EY tenure, Ms. Cherwoo also served as a Senior Advisory Partner in EY’s Private Equity practice group, from 2009 and served financial services clients as a Global Client Service Partner and Global Tax Account Leader, from 1991. From 2001 to 2004, Ms. Cherwoo served as the founding Chief Executive Officer of EY’s Global Shared Services operations in Bangalore, India, which was EY’s first global offshoring center for client-facing operations. Ms. Cherwoo currently serves on the board of World Kinect Corporation and is a former board member of Doma Holdings Inc. and World Quantum Growth Acquisition Corporation. In addition, Ms. Cherwoo has been an Executive in Residence at Columbia Business School since 2023, a member of the Advisory Board of Land O’Lakes Inc. since 2020, a Board Director of Tax Analysts since 2020, a board member of the National Association of Corporate Directors – New York Chapter since 2021, and a member of the Board of Trustees of International House of New York since 2008. Ms. Cherwoo is a Certified Public Accountant and holds a B.Sc. in Accounting as Valedictorian from Sacred Heart University in Fairfield, Connecticut. Ms. Cherwoo has also attended Executive Education programs at Harvard Business School for Strategic Leadership for EY Partners and at Northwestern University, Kellogg School of Management. | |||
Qualifications: Ms. Cherwoo had a distinguished career as a former senior partner at EY and has extensive knowledge and expertise in the private equity, financial services, and health care industries. | Committees: •Audit Committee Skills and Experience: •Accounting and Finance; Financial Services; Global Perspective; Risk Management and Compliance; Senior Executive and Corporate Governance; Sustainability; Technology and/or Cybersecurity | ||
![]() LINDA H. FILLER Independent Director Age: 65 Director Since: 2022 Class: II (expires 2025) | |||
Ms. Filler was appointed to our Board of Directors effective April 1, 2022, and is a member of the Nominating and Governance Committee. Ms. Filler retired as President of Retail Products, Chief Marketing Officer, and Chief Merchandising Officer at Walgreen Co. in 2017. Prior to Walgreen Co, Ms. Filler served in Executive Vice President roles at Walmart and at Kraft Foods. Prior to Kraft, Ms. Filler served a long tenure at Hanesbrands, including Group CEO roles of its largest branded apparel businesses. Ms. Filler is Lead Independent Director at Danaher Corporation, where she has served as a Director since 2004. She serves as Chair of the Nominating & Governance Committee and on the Science & Technology Committee. Ms. Filler also serves as Chair of Veralto Corporation, and on its Compensation Committee. Among other philanthropic activities, Ms. Filler serves as Chair of the Development Committee for the Chicago Public Library Foundation, and on the Foundation’s Executive Committee. Ms. Filler earned an MBA from Harvard Business School and an MS from the University of North Texas. | |||
Qualifications: Ms. Filler has extensive experience in senior management roles and expertise in marketing and branding and corporate strategy, as well as experience as a lead independent director in large, global businesses. | Committees: •Nominating and Corporate Governance Committee Skills and Experience: •Accounting and Finance; Branding and Marketing; Global Perspective; Senior Executive and Corporate Governance; Succession Planning and Human Capital Management; Sustainability | ||
10 | CARLYLE | Proxy Statement 2025 |
Corporate Governance |
![]() JAMES H. HANCE, JR. Operating Executive and Director Age: 80 Director Since: 2012 Class: II (expires 2025) | |||
Mr. Hance is an Operating Executive of Carlyle and a member of our Board of Directors. Mr. Hance was appointed to our Board of Directors effective May 2, 2012. Mr. Hance joined Carlyle in November 2005 as an Operating Executive and has worked primarily in our Global Credit segment and the financial services sector. Prior to joining Carlyle in 2005, Mr. Hance served as Vice Chairman of Bank of America from 1993 until his retirement on January 31, 2005 and served as Chief Financial Officer from 1988 to 2004. Prior to joining Bank of America, Mr. Hance spent 17 years with Price Waterhouse (now Pricewaterhouse Coopers LLP). Mr. Hance is currently a director of Acuity Brands Inc. (where he serves as the Lead Independent Director and on the Audit Committee and Governance Committee). Mr. Hance is a former director of Ford Motor Company, Sprint Nextel Corporation, Morgan Stanley, Duke Energy Corporation, Cousins Properties, Parkway, Inc. and Bank of America Corporation. Mr. Hance serves as Emeritus Trustee on the Board of Trustees at Washington University in St. Louis and as Chairman of the Board of Trustees at Johnson & Wales University in Providence, RI. Mr. Hance graduated from Westminster College and received an MBA from Washington University in St. Louis. He is a Certified Public Accountant. | |||
Qualifications: Mr. Hance has an invaluable perspective owing to his experience in various senior leadership roles in the financial services industry, including his role as the Chief Financial Officer of Bank of America Corporation, as well as his familiarity with our business and operations as an Operating Executive of Carlyle. | Committees: •None Skills and Experience: •Accounting and Finance; Financial Services; Global Perspective; Risk Management and Compliance; Senior Executive and Corporate Governance; Technology and/or Cybersecurity | ||
![]() DERICA W. RICE Independent Director Age: 60 Director Since: 2021 Class: II (expires 2025) | |||
Mr. Rice was appointed to our Board of Directors effective March 8, 2021, and is a member of the Audit and Compensation Committees. Mr. Rice served as executive vice president of CVS Health and President of CVS Caremark, the pharmacy benefits management business of CVS Health, from March 2018 to February 2020. Previously, he held various executive positions at Eli Lilly and Company, most recently executive vice president of Global Services and chief financial officer from 2006 to 2017. Mr. Rice is currently a director of Bristol-Meyers Squibb Company (where he serves on the Audit Committee and the Compensation and Management Development Committee), Target Corporation (where he serves on the Audit and Finance Committee and the Infrastructure and Investment Committee) and The Walt Disney Company (where he serves on the Audit Committee). Mr. Rice received his Bachelor of Science degree in Electrical and Electronics Engineering from Kettering University and an MBA from Indiana University. | |||
Qualifications: Mr. Rice has experience with complex, global business operations, and extensive knowledge of a wide range of financial and accounting matters resulting from his distinguished career at CVS Health and Eli Lilly and Company and significant experience as a director at large, global businesses. | Committees: •Audit Committee •Compensation Committee Skills and Experience: •Accounting and Finance; Branding and Marketing; Global Perspective; Government, Public Policy, and Regulatory Affairs; Risk Management and Compliance; Senior Executive and Corporate Governance; Succession Planning and Human Capital Management; Sustainability | ||
CARLYLE | Proxy Statement 2025 | 11 |
Corporate Governance |
![]() WILLIAM J. SHAW Independent Director Age: 79 Director Since: 2012 Term: 2025 | |||
Mr. Shaw was appointed to our Board of Directors effective May 2, 2012, and is the Chairperson of the Audit Committee. Mr. Shaw was the Vice Chairman of Marriott International, Inc. until his retirement in March 2011. Prior to becoming Vice Chairman of Marriott, Mr. Shaw served as President and Chief Operating Officer of Marriott from 1997 until 2009. Mr. Shaw joined Marriott in 1974 and held various positions, including Corporate Controller, Corporate Vice President, Senior Vice President-Finance, Treasurer, Chief Financial Officer, Executive Vice President and President of Marriott Service Group. Prior to joining Marriott, Mr. Shaw worked at Arthur Andersen & Co. Mr. Shaw is Chairman of the Board of Directors of Marriott Vacations Worldwide Corporation, a Director of DiamondRock Hospitality (where he serves as Chairman of the Audit Committee and serves on the Compensation Committee and Nominating and Corporate Governance Committee) and is a former member of the Board of Trustees of three funds in the American Family of mutual funds from 2009 to 2015. Mr. Shaw serves on the Board of Trustees of the University of Notre Dame. Mr. Shaw graduated from the University of Notre Dame and received an MBA from Washington University in St. Louis. | |||
Qualifications: Mr. Shaw has an extensive financial background and public company operating and management experience resulting from his distinguished career in various senior leaderships roles at Marriott. | Committees: •Audit Committee (Chair) Skills and Experience: •Accounting and Finance; Global Perspective; Risk Management and Compliance; Senior Executive and Corporate Governance; Succession Planning and Human Capital Management; Technology and/or Cybersecurity | ||
12 | CARLYLE | Proxy Statement 2025 |
Corporate Governance |
![]() WILLIAM E. CONWAY, JR. Co-Founder and Co-Chairman of the Board Age: 75 Director Since: 2011 Class: III (expires 2026) | |||
Mr. Conway is a Co-Founder and Co-Chairman of the Board. Mr. Conway was appointed to our Board of Directors effective July 18, 2011. Previously, Mr. Conway served as our Interim Chief Executive Officer, Co-Chief Executive Officer, and Chief Investment Officer. Prior to forming Carlyle in 1987, Mr. Conway was the Senior Vice President and Chief Financial Officer of MCI Communications Corporation (“MCI”). Mr. Conway was a Vice President and Treasurer of MCI from 1981 to 1984. Mr. Conway is a board member of the John Carroll Society and former Chairman of the Board of Trustees of Johns Hopkins Medicine and a former trustee and Vice Chairman of the Board of Trustees of the Catholic University of America. He previously served as chairman and/or director of several public and private companies in which Carlyle had significant investment interests. Mr. Conway received his BA from Dartmouth College and his MBA in finance from The University of Chicago Booth School of Business. | |||
Qualifications: Mr. Conway is a co-founder of our firm and has played an integral role in our firm’s successful growth since its founding in 1987. He also has developed a unique and unparalleled understanding of our business. | Committees: •None Skills and Experience: •Accounting and Finance; Financial Services; Global Perspective; Senior Executive and Corporate Governance | ||
![]() AFSANEH BESCHLOSS Independent Director Age: 69 Director Since: 2024 Class: III (expires 2026) | |||
Ms. Beschloss was appointed to our Board of Directors effective May 1, 2024. Ms. Beschloss is an economist, a leader in sustainable and inclusive investing and policy, and founder and CEO of RockCreek, one of the world’s largest women-owned investment firms. Previously, she was Managing Director and partner at The Carlyle Group from 2001 to 2003. As the World Bank’s Treasurer and Chief Investment Officer, she led the Bank’s investments, balance sheet management, ratings, borrowings, and innovations in financial products and in technology. Prior to this, she led the World Bank’s investments and policy work in the renewable energy, power, and infrastructure sectors, notably pioneering investments in natural gas, wind, and solar energy. Previously, she worked in corporate finance at JP Morgan. Ms. Beschloss has advised various governments, central banks, and regulatory agencies on financial policy and energy policy. She serves on the boards of trustees of the Council on Foreign Relations, the Rockefeller Foundation, where she chairs the Investment Committee, the Bretton Woods Committee, where she co-chairs the Future of Finance Working Group, Georgetown University, and the PBS Foundation where she serves as chair. She was recognized by Carnegie Corporation in their “Great Immigrants, Great Americans 2020” list, received the Robert F. Kennedy Human Rights Ripple of Hope Award and the Institutional Investor Lifetime Achievement Award, and has been listed among the “Most Powerful Women in Banking” by American Banker. She is the co-author of The Economics of Natural Gas (Oxford University Press) and author of numerous journal articles on innovations in finance, energy economics, and renewable energy investing. Ms. Beschloss holds an MPhil (Honors) in Economics from the University of Oxford, where she taught international trade and economic development. | |||
Qualifications: Ms. Beschloss has extensive investment, economic, and international experience, including in the financial and energy policy areas, as well as significant foreign affairs and government experience. | Committees: •None Skills and Experience: •Financial Services; Global Perspective; Government, Public Policy, and Regulatory Affairs; Senior Executive and Corporate Governance; Succession Planning and Human Capital Management; Sustainability; Technology and/or Cybersecurity | ||
CARLYLE | Proxy Statement 2025 | 13 |
Corporate Governance |
![]() LAWTON W. FITT Independent Director Age: 71 Director Since: 2012 Class: III (expires 2026) | |||
Ms. Fitt was appointed to our Board of Directors effective May 2, 2012, and is the Chairperson of the Nominating and Corporate Governance Committee and a member of the Audit and Compensation Committees. Ms. Fitt served as Secretary (CEO) of the Royal Academy of Arts in London from October 2002 to March 2005. Prior to that, Ms. Fitt was a partner with Goldman Sachs & Co. Ms. Fitt is currently a director of Ciena Corporation (where she serves as Chair of the Board and is a member of the Audit and Nominating and Governance Committees) and The Progressive Corporation (where she serves as Chairperson, and serves on the Investment and Capital Committee and as chair of the Nominating and Governance Committee). Ms. Fitt is a former director of Micro Focus International, ARM Holdings PLC, and Thomson Reuters. She is also a trustee or director of several not-for-profit organizations including the Goldman Sachs Foundation. Ms. Fitt earned her AB in history at Brown University and her MBA from the Darden School of the University of Virginia. | |||
Qualifications: Ms. Fitt has an extensive financial background and experience in a distinguished career at Goldman Sachs in the areas of investment banking and risk analysis, including her unique insights into the operation of global capital markets. | Committees: •Audit Committee •Compensation Committee •Nominating and Corporate Governance Committee (Chair) Skills and Experience: •Accounting and Finance; Financial Services; Global Perspective; Risk Management and Compliance; Senior Executive and Corporate Governance; Succession Planning and Human Capital Management | ||
![]() MARK S. ORDAN Lead Independent Director Age: 66 Director Since: 2022 Class: III (expires 2026) | |||
Mr. Ordan was appointed to our Board of Directors effective April 1, 2022, serves as our Lead Independent Director, and is a member of the Compensation and Nominating and Corporate Governance Committees. Mr. Ordan served as Executive Chair of Pediatrix Medical Group, a physician-led healthcare organization, from January 1, 2023 through January 10, 2025, when he was appointed to his current position of Chairman and Chief Executive Officer. Mr. Ordan formerly served as Chief Executive Officer of Pediatrix Medical Group from July 2020 through December 2022. Prior to joining Pediatrix Medical Group, Mr. Ordan founded and served as Chief Executive Officer of Quality Care Properties after serving as founding Chief Executive Officer of Washington Prime Group. Mr. Ordan has held a number of CEO roles including at Sunrise Senior Living, The Mills Corporation, and Balducci’s, and was founder and CEO of Fresh Fields Markets, which he later merged with Whole Foods Markets. Mr. Ordan is the Board Chair of the U.S. Chamber of Commerce. Mr. Ordan received his BA from Vassar College, and his MBA from Harvard Business School. He serves on the board of Holton-Arms School. | |||
Qualifications: Mr. Ordan has extensive leadership experience from serving as the CEO of various companies and resulting in considerable operational knowledge, as well as his prior experience as a director of other public company boards. | Committees: •Compensation Committee •Nominating and Corporate Governance Committee Skills and Experience: •Accounting and Finance; Branding and Marketing; Financial Services; Global Perspective; Government, Public Policy, and Regulatory Affairs; Senior Executive and Corporate Governance; Succession Planning and Human Capital Management | ||
14 | CARLYLE | Proxy Statement 2025 |
Corporate Governance |
![]() ANTHONY WELTERS Independent Director Age: 70 Director Since: 2015 Class: III (expires 2026) | |||
Mr. Welters was appointed to our Board of Directors effective October 27, 2015, and is the Chairperson of the Compensation Committee, as well as a member of the Nominating and Corporate Governance Committee. He is Founder, Chairman and CEO of CINQCARE Inc., a physician-led, community-based ambulatory care delivery system that delivers whole person care in the home, whenever possible. He is Executive Chairman of the BlackIvy Group, an organization focused on building and growing commercial enterprises in Sub-Saharan Africa, and Chairman of Somatus, Inc., a value-based kidney care company. Mr. Welters founded AmeriChoice in 1989 and upon acquisition by UnitedHealth Group (UHG) in 2002, joined UHG serving as Senior Adviser to the Office of the CEO, Executive Vice President and Member of the Office of the CEO, retiring in 2016. He currently serves on the public boards of Loews Corporation and Gilead Sciences, Inc. Mr. Welters is Trustee Emeritus of Morehouse School of Medicine Board of Trustees, Chairman Emeritus of the Board of New York University School of Law, Vice Chairman of the Board of New York University, a Trustee of NYU Langone Medical Center, Vice Chair of the John F. Kennedy Center for the Performing Arts and a founding member of the National Museum of African American History and Culture. | |||
Qualifications: Mr. Welters has extensive entrepreneurial and operating expertise, as well as a familiarity with board responsibilities, oversight and control resulting from his significant experience serving on the boards of directors of various public companies. | Committees: •Compensation Committee (Chair) •Nominating and Corporate Governance Committee Skills and Experience: •Global Perspective; Senior Executive and Corporate Governance; Succession Planning and Human Capital Management | ||
CARLYLE | Proxy Statement 2025 | 15 |
Corporate Governance |

16 | CARLYLE | Proxy Statement 2025 |
Corporate Governance |
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ||
![]() | Accounting and Finance. Directors bring expertise in financial reporting, audit knowledge, and experience in capital markets. | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | |||
![]() | Branding and Marketing. Directors bring expertise in brand development, marketing, and sales at a global scale and in local markets relevant to Carlyle’s business. | ![]() | ![]() | ![]() | ![]() | ![]() | ||||||||
![]() | Financial Services. Directors possess in- depth knowledge of the financial services industry or private equity. | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ||||
![]() | Global Perspective. Directors provide valuable insights on how Carlyle should continue to grow and manage its businesses outside the United States. | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
![]() | Government, Public Policy, and Regulatory Affairs. Directors possess insight and experience in managing governmental and regulatory affairs. | ![]() | ![]() | ![]() | ![]() | ![]() | ||||||||
![]() | Risk Management and Compliance. Directors possess in-depth knowledge and experience with risk management and compliance matters relevant to Carlyle’s global business. | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ||||||
![]() | Senior Executive and Corporate Governance. Directors bring valuable insight and senior executive experience on matters relating to corporate governance, management, operations, and compensation. | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
![]() | Succession Planning and Human Capital Management. Directors bring expertise in ensuring Carlyle has sufficient talent, robust development and retention practices and supporting our people and culture. | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | |||||
![]() | Sustainability. Directors bring experience in the areas of environmental impact, climate change, corporate responsibility, or sustainability strategies. | ![]() | ![]() | ![]() | ![]() | ![]() | ||||||||
![]() | Technology and/or Cybersecurity. Directors possess experience in the development and adoption of new technology or the management of information security or cybersecurity risks at companies. | ![]() | ![]() | ![]() | ![]() | ![]() | ||||||||
CARLYLE | Proxy Statement 2025 | 17 |
Corporate Governance |
18 | CARLYLE | Proxy Statement 2025 |
Corporate Governance |
Strategy | Risk Management and Cybersecurity | CEO and Financial Performance and Reporting | ||
Succession Planning and Human Capital Management | People and Culture | Sustainability |
CARLYLE | Proxy Statement 2025 | 19 |
Corporate Governance |
BOARD OVERSIGHT | ||||
•Our Board is responsible for oversight of the firm’s enterprise risk management strategy and its risk tolerance. •Other areas of risk management addressed by the Board include, among others, global and regional market dynamics, political and legislative risk, and environmental and social risk. While the full Board exercises responsibility for enterprise risk management, each Board committee maintains appropriate risk oversight within the scope of its committee function. | ||||
![]() | ||||
AUDIT COMMITTEE | COMPENSATION COMMITTEE | NOMINATING AND CORPORATE GOVERNANCE COMMITTEE | ||
•Undertakes oversight of financial, tax, legal and compliance risks. •Monitors the adequacy of our capital and liquidity positions. •Oversees risks relating to technology and information security, including cybersecurity. | •Oversees risks relating to our compensation programs and strategies for attracting, motivating and retaining employees, and aligning their interests with those of our business and our shareholders. | •Oversees risk relating to the effectiveness of our Board, the quality of leadership, and succession planning. •Oversees our approach to sustainability strategy. | ||
![]() | ||||
LEADERSHIP TEAM | ||||
•With the guidance and oversight of the Board and its committees, management of day-to-day judgments on risk matters throughout the business has been delegated to the leadership team. | ||||
20 | CARLYLE | Proxy Statement 2025 |
Corporate Governance |
SELECT CYBERSECURITY BEST PRACTICES •Multi-factor authentication for remote access, privileged access management for system administrators, application whitelisting, laptop encryption, mobile device management software, and advanced malware defenses on endpoints •Incident preparedness and response planning and risk mitigation •Independent and continuous security testing, assessment, third-party risk, and vulnerability management •Regular security awareness training, including phishing simulations, for Carlyle authorized users •Restrictions on access to personal email accounts, cloud storage, social media, risk-based categories of websites, and USB storage devices •Device and system access management policies and procedures that restrict access upon employee or contractor separation from the Company •Compliance attestations by Carlyle personnel on firm policies, such as our acceptable use policy, upon hire and annually |
CARLYLE | Proxy Statement 2025 | 21 |
Corporate Governance |
22 | CARLYLE | Proxy Statement 2025 |
Corporate Governance |
AUDIT COMMITTEE | ||
![]() William J. Shaw Chair Members: Sharda Cherwoo Lawton W. Fitt Derica W. Rice Meetings in 2024: 10 | Principal Responsibilities: The purpose of the Audit Committee is to provide assistance to the Board in fulfilling its obligations with respect to matters involving our accounting, auditing, financial reporting, internal control, and legal compliance functions, including, without limitation, assisting the Board’s oversight of: •the quality and integrity of our financial statements, •our compliance with legal and regulatory requirements, •our independent registered public accounting firm’s qualifications and independence, •the performance of our independent registered public accounting firm and our internal audit function, •directly appointing, retaining, reviewing, and terminating our independent registered public accounting firm, and •our technology and information security, including cybersecurity. The members of our Audit Committee have not participated in the preparation of our financial statements at any time during the past three years and meet the financial sophistication requirements for service on an audit committee of a board of directors pursuant to the Nasdaq Listing Rules relating to corporate governance matters. The Board has determined that Mr. Shaw, Ms. Cherwoo, Ms. Fitt, and Mr. Rice are each an “audit committee financial expert” within the meaning of Item 407(d)(5) of Regulation S-K. The Audit Committee’s charter is available on our website at ir.carlyle.com. | |
COMPENSATION COMMITTEE | ||
![]() Anthony Welters Chair Members: Lawton W. Fitt Mark S. Ordan Derica W. Rice Meetings in 2024: 6 | Principal Responsibilities: Our Compensation Committee is responsible for, among other duties and responsibilities: •reviewing and approving, or recommending to the Board for approval, all forms of compensation to be provided to, and employment agreements with, our executive officers, •establishing and reviewing our overall compensation philosophy, •reviewing and approving, or recommending to the Board for approval, awards under our equity incentive plan, and overseeing the administration of our equity incentive plan, and •reviewing, approving and monitoring our Stock Ownership Guidelines and clawback policies (including our Incentive Compensation Clawback Policy and our Dodd-Frank Incentive Compensation Clawback Policy). In addition, the Compensation Committee may delegate any or all of its responsibilities to a subcommittee of the Compensation Committee. The Compensation Committee may also delegate to one or more officers of the Company the authority to make certain grants and awards under the Company’s equity incentive plan to employees of the Company or its affiliates who are neither directors or executive officers, as the Compensation Committee deems appropriate and in accordance with the terms of such plan, provided that such delegation is in compliance with the plan and the laws of the State of Delaware. The Compensation Committee’s charter is available on our website at ir.carlyle.com. | |
CARLYLE | Proxy Statement 2025 | 23 |
Corporate Governance |
NOMINATING AND CORPORATE GOVERNANCE COMMITTEE | ||
![]() Lawton W. Fitt Chair Members: Linda H. Filler Mark S. Ordan* Anthony Welters Meetings in 2024: 3 * Appointed on April 7, 2025. | Principal Responsibilities: Our Nominating and Corporate Governance Committee is responsible for, among other duties and responsibilities: •identifying candidates qualified to serve on our Board, •reviewing the composition of the Board and its committees, •developing and recommending to the Board corporate governance principles that are applicable to us, •overseeing the evolution of the Board, and •taking a leadership role in shaping our corporate governance, including oversight of and approach to sustainability strategy. The Nominating and Corporate Governance Committee’s charter is available on our website at ir.carlyle.com. | |
24 | CARLYLE | Proxy Statement 2025 |
Corporate Governance |
ENGAGEMENT | ![]() | COMMUNICATION | ![]() | FEEDBACK |
The leadership team, Investor Relations, and the Corporate Secretary regularly engage with our shareholders to solicit feedback on a variety of corporate governance matters, including, among others, executive compensation, corporate governance, and sustainability. Our directors also engage with our shareholders. | We routinely interact and communicate with our shareholders through a number of other forums, including quarterly earnings presentations and calls, SEC filings, the Annual Report and the Proxy Statement, the Annual Meeting of Shareholders, investor meetings, and conferences. | We review shareholder feedback and trends and developments about corporate governance matters with our Board and the Nominating and Corporate Governance Committee as we seek to enhance our corporate governance profile and improve our disclosures. | ||
![]() | ![]() | |||
2024 ENGAGEMENT OVERVIEW | ||||
•60% of shares outstanding contacted | •51% of shares outstanding engaged | •63% of meetings with Board participation | ||
CARLYLE | Proxy Statement 2025 | 25 |
Item 2 | Ratification of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2025 | |||
Our Audit Committee has selected Ernst & Young as our independent registered public accounting firm to perform the audit of our consolidated financial statements for 2025. Representatives of Ernst & Young are expected to be present at our Annual Meeting, will have an opportunity to make a statement if they so desire, and will be available to respond to appropriate questions. | ||||
FOR ![]() | BOARD RECOMMENDATION | |||
The Board unanimously recommends a vote “FOR” the ratification of the selection of Ernst & Young as our independent registered public accounting firm for 2025. | ||||
The appointment of Ernst & Young as our independent registered public accounting firm for 2025 is being submitted to our shareholders for ratification at the Annual Meeting. Our Board recommends that shareholders vote “FOR” the ratification of the selection of Ernst & Young as our independent registered public accounting firm. The submission of the appointment of Ernst & Young is required neither by law nor by our bylaws. Our Board is nevertheless submitting this matter to our shareholders to ascertain their views. If our shareholders do not ratify the appointment, the selection of another independent registered public accounting firm may be considered by the Audit Committee. Even if the selection is ratified, the Audit Committee in its discretion may select a different independent registered public accounting firm at any time during the year if it determines that such a change would be in the best interests of the Company and our shareholders. | ||||
26 | CARLYLE | Proxy Statement 2025 |
Audit Matters |
Year Ended December 31, 2024 | ||||||||
The Carlyle Group Inc. | Carlyle Funds | Total | ||||||
Audit Fees | $5.7 | (a) | $34.7 | (d) | $40.4 | |||
Audit-Related Fees | 0.5 | (b) | 14.1 | (e) | 14.6 | |||
Tax Fees | ||||||||
Tax Compliance | 1.4 | 0.4 | 1.8 | |||||
Tax Advisory | 4.8 | 0.1 | 4.9 | |||||
Total Tax Fees | $6.2 | (c) | $0.5 | (d) | $6.7 | |||
All Other Fees | — | — | — | |||||
Total | $12.4 | $49.3 | $61.7 | |||||
Year Ended December 31, 2023 | ||||||||
The Carlyle Group Inc. | Carlyle Funds | Total | ||||||
Audit Fees | $4.9 | (a) | $33.8 | (d) | $38.7 | |||
Audit-Related Fees | 0.2 | (b) | 16.6 | (e) | 16.8 | |||
Tax Fees | ||||||||
Tax Compliance | 1.1 | 0.5 | 1.6 | |||||
Tax Advisory | 2.0 | 0.6 | 2.6 | |||||
Total Tax Fees | $3.1 | (c) | $1.1 | (d) | $4.2 | |||
All Other Fees | — | — | — | |||||
Total | $8.2 | $51.5 | $59.7 | |||||
CARLYLE | Proxy Statement 2025 | 27 |
Audit Matters |
William J. Shaw (Chair) Sharda Cherwoo Lawton W. Fitt Derica W. Rice |
28 | CARLYLE | Proxy Statement 2025 |
![]() | Harvey M. Schwartz Chief Executive Officer and Director Age: 61 | |
Mr. Schwartz is the Chief Executive Officer of Carlyle and member of the Board of Directors. He has served in such capacity since February 15, 2023, and is based in New York. Mr. Schwartz formerly worked at Goldman Sachs from 1997 to 2018, with his last position being President and Co-Chief Operating Officer. He also held numerous senior leadership positions including Chief Financial Officer and Global Co-Head of the Securities Division. Mr. Schwartz started his career at J. B. Hanauer & Co., and then moved to First Interregional Equity Corporation. In 1989, he joined Citigroup, where he worked in the firm's credit training program and developed a specialty in structuring commodity derivatives. Mr. Schwartz serves on the board of One Mind, a nonprofit that accelerates collaborative research and advocacy to enable all individuals facing brain health challenges to build healthy, productive lives. Mr. Schwartz previously served on the board of Sofi Technologies, Inc. from May 2021 through November 2024. He is involved in a range of investment and philanthropic endeavors that include a focus on mental health and developing future business leaders, including women and young people seeking a career in finance. Mr. Schwartz earned his BA from Rutgers University, where he is a member of the university’s Board of Governors and its Hall of Distinguished Alumni. He received his MBA from Columbia University. | ||
![]() | John C. Redett Chief Financial Officer and Head of Corporate Strategy Age: 57 | |
Mr. Redett is the Chief Financial Officer and Head of Corporate Strategy at Carlyle. He is based in New York. Mr. Redett joined Carlyle in 2007 as an investor on the Global Financial Services team. He formerly served as the sole Head of Global Financial Services from 2020 to September 2023 and the Co-Head of Global Financial Services from 2016 to 2020. Mr. Redett is a 25-year veteran of the financial services industry and has been deeply involved in the operations and management of many financial services businesses during his career. He has led or been a key contributor to some of Carlyle’s significant investments across various subsectors of financial services, including Duff & Phelps, TCW, BankUnited, Hilb Group, EPIC, DBRS, Central Pacific Bank, CFGI, PIB Group, and JenCap. He currently serves on the boards for Hilb Group and NSM Insurance Group. Prior to joining Carlyle, Mr. Redett worked at Goldman Sachs from 2005 to 2007, and JPMorgan from 2000 to 2005. He received an MBA from New York University and a BS from the University of Colorado. | ||
CARLYLE | Proxy Statement 2025 | 29 |
Executive Officers |
![]() | Lindsay P. LoBue Chief Operating Officer Age: 50 | |
Ms. LoBue is the Chief Operating Officer of Carlyle. She is based in New York. Ms. LoBue is a member of Carlyle’s Leadership and Operating Committees. Previously, she was Deputy COO of Carlyle from February 2024 to June 2024. Prior to that, Ms. LoBue spent over 20 years at Goldman Sachs, most recently as an Advisory Director working across global divisions on strategic growth initiatives. Before that, Ms. LoBue was a Partner in the Global Markets division, responsible for leading and managing client-facing businesses in a variety of areas. She managed the firm’s Investment Grade Corporate Bond sales team, founded and led the Credit Products Group, and drove the revenue growth of the firm’s Structured Products, Relative Value and Solutions, and Credit Derivatives franchise efforts. Prior to joining Goldman Sachs, Ms. LoBue was a Structured Products Salesperson and CMBS Research Analyst at J.P. Morgan. Ms. LoBue was also the founder of Greenback Labs, a platform that focused on advancing emerging ideas and businesses by working with entrepreneurs to validate business ideas and execute growth strategies. Ms. LoBue is a Board Member of Enel Finance Americas, the financing arm within the Enel Group, and she is a member of the Board of Regents at Boston College. Ms. LoBue has an MBA in Finance and Marketing from NYU, and a Bachelor of Science in Marketing and Psychology from Boston College. | ||
![]() | Jeffrey W. Ferguson General Counsel Age: 59 | |
Mr. Ferguson is the General Counsel of Carlyle. He is based in Washington, DC. Mr. Ferguson joined Carlyle in 1999. In his capacity as the global General Counsel of Carlyle, he serves as the head of the firm’s legal and compliance functions. He is also a member of Carlyle’s Leadership, Operating, and Risk Committees. Prior to joining Carlyle, Mr. Ferguson worked as an attorney with Latham & Watkins and Vinson & Elkins. Mr. Ferguson received his law degree from University of Virginia School of Law in 1991. He also received an undergraduate degree in political science from University of Virginia, where he was a member of Phi Beta Kappa. Mr. Ferguson is a member of the bars of the District of Columbia and Virginia. | ||
30 | CARLYLE | Proxy Statement 2025 |
Item 3 | Non-Binding Vote to Approve Named Executive Officer Compensation (“Say-on-Pay”) | |||
In accordance with the requirements of Section 14A of the Securities Exchange Act of 1934, as amended, and the related rules of the SEC, we are including in these proxy materials a separate resolution subject to shareholder vote to approve, in a non-binding advisory vote, the compensation of our named executive officers as disclosed above. The text of the resolution in respect of Proposal 3 is as follows: “RESOLVED, that the compensation paid to the Company’s named executive officers as disclosed in this Proxy Statement pursuant to the rules of the SEC, including the Compensation Discussion and Analysis, compensation tables, and any related narrative discussion, is hereby APPROVED.” In considering their vote, shareholders may wish to review with care the information on our compensation policies and decisions regarding the named executive officers presented in the Compensation Discussion and Analysis set forth below, including the Shareholder Engagement on Executive Compensation section that details our year-round shareholder engagement process. In particular, shareholders should note that we base our executive compensation decisions on the following: •a strong emphasis on financial performance, with an additional lens to assess against key strategic initiatives and individual performance, •an appropriate link between compensation and the creation of shareholder value through equity awards, and •long-term incentive awards that do not promote excessive risk taking. While the results of the vote are non-binding and advisory in nature, the Board intends to carefully consider the results of the vote. The next non-binding vote to approve the compensation of our named executive officers is expected to be held at the Company’s 2026 Annual Meeting of Shareholders. | ||||
FOR ![]() | BOARD RECOMMENDATION | |||
The Board recommends a vote “FOR” the approval of the compensation of our named executive officers. | ||||
CARLYLE | Proxy Statement 2025 | 31 |
Compensation Matters |
32 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
WHAT WE DO: | |
Align pay with firm performance and shareholder ![]() interests, including through use of RSUs and PSUs Large majority of compensation is variable, and the ![]() majority is delivered in equity Long-term incentive awards are denominated and ![]() settled in equity Regularly engage with shareholders as part of our ![]() year-round, proactive engagement Engage an independent compensation consultant that ![]() works directly for our Compensation Committee and does no work for management Tie incentive compensation to a clawback policy that ![]() cover financial restatements, with one policy extending beyond the mandates of the Dodd-Frank Act and including recoupment upon detrimental activity | Require our executive officers to own a minimum value ![]() of shares of our common stock and retain a portion of certain RSU and PSU awards for a fixed minimum period following vesting Hold an annual Say-on-Pay vote and disclose response ![]() to shareholder feedback Perform an annual compensation risk assessment ![]() For our CEO’s Sign-On PSU Award, full vesting requires ![]() both 110% stock price appreciation over the 5-year performance period and relative total shareholder return (“TSR”) performance at the 60th percentile versus S&P 500 Financials Index constituent companies Require a qualifying termination of employment following ![]() a change in control of Carlyle in order for any such change in control to trigger accelerated vesting rights |
WHAT WE DO NOT DO: | |
No excise tax “gross-up” payments in the event of a ![]() change in control No tax “gross-up” payment in perquisites for named ![]() executive officers No defined benefit plan pension benefits for ![]() executive officers No short sales or derivative transactions in our equity or ![]() hedging our common stock, and we generally prohibit pledging of our stock absent prior approval | No dividends paid in cash on unvested equity awards ![]() Do not count unvested PSUs or unexercised ![]() stock options toward satisfaction of stock ownership guidelines No repricing of underwater stock options ![]() No changes to performance targets for legacy ![]() performance-vesting awards |
CARLYLE | Proxy Statement 2025 | 33 |
Compensation Matters |
CEO Pay Mix | Average Other NEO Pay Mix | ||||
![]() | ![]() | ||||
96.4% Variable and At-Risk Pay | 97.5% Variable and At-Risk Pay | ||||

34 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
2024 Engagement Overview •Year-round, proactive engagement •60% of shares outstanding contacted •51% of shares outstanding engaged •63% of meetings with Board participation |

![]() | ![]() | ![]() | ![]() | |||
Spring •Publish our Proxy Statement and Annual Report •Engage with shareholders on Proxy Statement voting items •Hold Annual Meeting of Shareholders | Summer •Discuss Annual Meeting voting results and shareholder feedback with Board to determine appropriate next steps, if any •Conduct Board self- assessment •Publish annual Sustainability Report | Fall •Engage with shareholders on topics such as governance, compensation, and sustainability •Review shareholder proposals, if any | Winter •Assess governance practices and policies •Review committee charters •Discuss shareholder feedback from fall engagement meetings with Board | |||
CARLYLE | Proxy Statement 2025 | 35 |
Compensation Matters |
PAY-FOR- PERFORMANCE | ![]() | ALIGNMENT | ![]() | BALANCE |
Establish a clear relationship between performance and compensation | Align short-term and long-term incentives with our business, our shareholders and our fund investors | Provide competitive incentive opportunities, with an appropriate balance between short-term and long-term incentives | ||
![]() | ![]() | |||
BUSINESS GOALS AND OBJECTIVES | ||||
We seek to incentivize our named executive officers and other senior leaders to achieve our goals and objectives and to execute and deliver strong financial results for all our shareholders and other stakeholders. We believe that a key to achieving our goals and objectives is an organized, unbiased approach to compensation that is transparent and agile in response to our business needs and an evolving economy and industry. | ||||
36 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
CARLYLE | Proxy Statement 2025 | 37 |
Compensation Matters |
Compensation Element | CEO | Other NEOs | Purpose and Alignment | |
Cash | Base Salary | ![]() | ![]() | Provides a base compensation floor. Not intended to be a significant element of compensation. |
Annual Performance Bonus | ![]() | ![]() | Rewards achievement of key strategic and financial priorities. | |
Long-Term Equity Awards Granted in 2024 Granted February 2024 | Annual/ Discretionary Time- Vesting RSUs | ![]() | Generally awarded annually based on prior year performance. Aligns our NEOs with our shareholders through share ownership. Promotes continued retention of our NEOs. | |
Bonus Deferral Program RSUs | ![]() | Converts a portion of the annual performance bonus otherwise payable in cash to an RSU award vesting over 3 years. Further drives alignment between our NEOs and our shareholders by promoting share ownership. | ||
Stock Price Appreciation Program PSUs | ![]() | ![]() | Drives stock price appreciation by linking vesting to rigorous stock price appreciation targets over 3 years, with 60% appreciation required for full vesting. Designed based on the feedback received from shareholders and further aligns our NEOs with our shareholders. | |
Long-Term Equity Awards Granted in 2025 Granted February 2025 | Annual/ Discretionary Time- Vesting RSUs | ![]() | Generally awarded annually based on prior year performance. Aligns our NEOs with our shareholders through share ownership. Promotes continued retention of our NEOs. | |
Bonus Deferral Program RSUs | ![]() | Converts a portion of the annual performance bonus otherwise payable in cash to an RSU award vesting over 3 years. Further drives alignment between our NEOs and our shareholders by promoting share ownership. | ||
Stock Price Appreciation Program PSUs | ![]() | Drives stock price appreciation by linking vesting to rigorous stock price appreciation targets over 3 years, with 60% appreciation required for full vesting. Designed based on the feedback received from shareholders and further aligns our NEOs with our shareholders. | ||
2023 CEO Sign-On Awards | Sign-On PSUs | ![]() | Granted in connection with Mr. Schwartz’s hiring in February 2023. Aligns the interests of our CEO with those of our shareholders. With respect to the Sign-On PSUs, drives both stock price appreciation over 5 years and strong relative performance, with 110% appreciation and superior outperformance relative to the constituent companies in the S&P 500 Financial Index required for full vesting. | |
Sign-On RSUs | ![]() | |||
Legacy Long-Term Equity Awards | Performance- Vesting Strategic Equity Award Program RSUs Fourth Tranche (2024) | ![]() | Fourth and final tranche of RSU awards granted in 2021 in connection with the implementation of our then-new Strategic Plan with performance goals tied to FRE achievement in 2024. Incentivized the retention of our executives and achievement of key financial performance metrics linked to the Strategic Plan. | |
38 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
Name | 2023 Base Salary | 2024 Base Salary | % Change | |||
Harvey Schwartz | $1,000,000 | $1,000,000 | — | |||
John Redett | $500,000 | $500,000 | — | |||
Lindsay LoBue | $500,000 | $500,000 | — | |||
Jeffrey Ferguson | $500,000 | $500,000 | — | |||
Christopher Finn | $500,000 | $500,000 | — | |||
CARLYLE | Proxy Statement 2025 | 39 |
Compensation Matters |

40 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
![]() | Harvey M. Schwartz Chief Executive Officer and Director | ![]() | |||||
2024 Annual Performance Bonus | |||||||
Overall Achievement Rating: | 200% | ||||||
Annual Performance Bonus: | $6,000,000 | ||||||
Financial Performance Metric Evaluation | ||||||
Target Bonus Weight and Bonus Objective | Threshold (50% of Target Payout) | Target (100% of Target Payout) | Maximum (200% of Target Payout) | Achievement Rating | Weighted Payout | |
![]() | FRE | ![]() | 200% | 100% | ||
Qualitative Performance Metric Evaluation | ||||
Target Bonus Weight and Bonus Objective | Performance Factors Considered | Achievement Rating | Weighted Payout | |
![]() Business Development Initiatives | •Oversaw the disciplined deployment of capital and resources, with a focus on strategic capital allocation and dilution management and an intentional shifting of resource allocation to businesses with higher growth potential. •Approved multiple strategic and organic growth initiatives, primarily focusing on semi-liquid offerings and business adjacencies, while instituting a structured and thorough diligence process. •Developed and grew our wealth business by appointing new leadership to integrate and expand the wealth platform, strategically increasing headcount, raising $4.5 billion, launching two evergreen products, and securing significant mandates that expanded the wealth footprint and strengthened our presence in international markets. •Drove significant progress in the insurance strategy, resulting in $77 billion AUM for 2024, as well as over $19 billion committed to various Carlyle strategies, and positioned the insurance business for future growth through engagement in strategic dialogue with global insurers. •Refocused and prioritized shareholder and limited partner relationships by participating in numerous shareholder meetings, limited partner meetings, and events reaching wealth advisors. •Elevated Carlyle’s public profile with key stakeholders through media efforts across various channels and multiple direct engagements with key financial reporters. | 200% | 33.33% | |
CARLYLE | Proxy Statement 2025 | 41 |
Compensation Matters |
Target Bonus Weight and Bonus Objective | Performance Factors Considered | Achievement Rating | Weighted Payout | |
![]() Leadership/ Organizational Design | •Continued to build senior leadership and governance structure at the corporate, segment, and function levels, enhanced succession planning for senior leadership roles, and led a structured review process to identify key talent and promote new leaders. •Restructured the firm’s operating model to enhance efficiency, accountability, and decision-making, incorporating new management reporting processes, strategic business reviews, and refinements to promotion and compensation processes to retain top talent. •Empowered senior leaders to build their leadership teams, focusing on promoting high-performers and strategic hires. •Focused on improving private equity performance, including through targeted promotions to lead such efforts. •Expanded employee engagement and internal communication through quarterly global town halls, in-office gatherings, and speaker series with senior leaders, facilitating better linkage and collaboration among employees across departments and geographies. | 200% | 33.33% | |
![]() Compensation Strategy | •Oversaw the design and launch of the Stock Price Appreciation PSU Award Program to incentivize senior leaders best-positioned to drive growth with our shareholders by tying the awards to stock price performance. •Developed the strategy around the expanded RSU Bonus Deferral Program, which strengthens the alignment of a broad group of employees with our shareholders and the overall success of the firm through enhanced equity ownership. •Significantly improved FRE margin (46% for 2024 up from 37% in 2023) and cash compensation ratio (36% for 2024 down from 45% in 2023) by running the business more efficiently to drive growth and performance. •Encouraged and rewarded scaling capital markets activity and cross-firm collaboration by enhancing the compensation structure for capital markets transactions, contributing to more than $163 million in transaction and portfolio advisory fees, net and other for 2024, more than double the $80 million in 2023. •Reinforced a pay-for-performance culture, encouraging leaders to differentiate compensation based on individual, team, and firm results. | 200% | 33.33% | |
Final Weighted Achievement Factor: | 200% | |||
Mr. Schwartz 2024 Annual Performance Bonus: | $6,000,000 | |||
42 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
![]() | John C. Redett Chief Financial Officer and Head of Corporate Strategy | ||||
2024 Annual Performance Bonus: | $3,000,000 | ||||
Cash Portion: | $2,005,000 | ||||
RSU Deferral Portion: | $995,000 | ||||
Drove Restructured Employee Compensation Program and Enhanced Pay-for-Performance Culture •Oversaw the design and launch of the Stock Price Appreciation PSU Award Program and expansion of the RSU Bonus Deferral Program, in order to strengthen alignment of employees with shareholders and the overall success of the firm. •Significantly improved FRE margin (46% for 2024 up from 37% in 2023) and the cash compensation ratio (36% in 2024 down from 45% in 2023) by running the business more efficiently and implementing a strategic compensation alignment program. •In collaboration with Mr. Schwartz and Ms. LoBue, reinforced a pay-for-performance culture, encouraging leaders to differentiate employee compensation based on individual, team, and firm results. Strengthened Capital Management, Optimizing Capital and Resource Deployment •Applied deep private equity expertise and institutional knowledge to drive disciplined capital deployment across investment strategies and business segments. •Conducted strategic review of business units to develop and refine both short-term and long-term growth strategies. •Focused on strategic capital allocation and dilution management, including increased repurchase activity, with approximately $555 million in shares of our common stock repurchased or withheld in 2024, thereby reducing total shares outstanding for the second consecutive year. •In collaboration with Mr. Schwartz, guided multiple strategic and organic growth initiatives, including the launch of new retail-focused product offerings and adjacent opportunities, supported by a robust diligence and review process. •Re-allocated resources and balance sheet capacity to higher potential business units to support sustained growth and profitability. Enhanced Shareholder and Investor Engagement Strategy •Drove our enhanced shareholder engagement strategy and strengthening of limited partner relationships by participating in extensive meetings and conferences in the United States and globally. •Elevated Carlyle’s public profile with key stakeholders through media efforts across various investment channels, including multiple direct engagements with key financial reporters. •Directed enhanced and year-round shareholder engagement efforts in connection with the Annual Meeting of Shareholders, resulting in valuable and actionable feedback on compensation and governance matters. | |||||
CARLYLE | Proxy Statement 2025 | 43 |
Compensation Matters |
![]() | Lindsay P. LoBue Chief Operating Officer | ||||
2024 Annual Performance Bonus: | $3,000,000 | ||||
Cash Portion: | $2,405,000 | ||||
RSU Deferral Portion: | $595,000 | ||||
Developed and Implemented New Strategic Approach to Firm Leadership and Governance •Successfully transitioned to the role of Chief Operating Officer to provide, in collaboration with Mr. Schwartz, new leadership and strategic vision across our business. •Led operations across our global platform, including active oversight across our business segments and functional teams, supporting new product development and growth initiatives and spearheading new projects to enhance operational efficiency and operating leverage. •Oversaw key functions including Human Capital Management, Global Technology & Solutions, Corporate Affairs, Global Research, Bank and Financial Institutions, and other operational and business teams, while actively managing strategic objectives and growth initiatives. •Served as chair of the firm’s Operating Committee and as an active member of other key firm committees including our Leadership Committee, Risk Committee, New Products and Distribution Committee, Technology Investment Committee, and other key governing groups at the firm. •Served as a visible and active representative of the senior leadership of the firm in speaking at and attending numerous employee town hall meetings, employee resource group meetings, and other firm events that are key to maintaining our corporate culture and instilling our corporate values across the global employee base. Enhanced Client Service and Initiatives •Enhanced direct engagement with key clients and strategic partners, ensuring alignment between the firm’s operational capabilities and client needs. •Leveraged years of client service experience to ensure the development of new business opportunities and products were driven by client needs. •Led firm-wide initiatives to streamline investor interactions and enhance digital client experiences. Strengthened Firm Operations and Strategic Growth Priorities •Designed a strategic framework and operating model to enhance profitability, operational efficiency, and long-term sustainability. •Drove numerous operating efficiency initiatives, including continued optimization of organizational structure and the creation of shared services. •Strengthened financial oversight through the implementation of expense management tools, and procurement strategies. •Drove evolved talent management and recruitment strategies to support growth. •Oversaw the firm’s automation and technology transformation efforts, leveraging digital tools to improve operational efficiency and deliver business growth. •Implemented enterprise-wide AI solutions, reducing manual processes and enhancing productivity, risk management, and investment execution. | |||||
44 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
![]() | Jeffrey W. Ferguson General Counsel | ||||
2024 Annual Performance Bonus: | $1,000,000 | ||||
Cash Portion: | $805,000 | ||||
RSU Deferral Portion: | $195,000 | ||||
Oversaw Global Legal and Compliance Team •Oversaw our global Legal and Compliance team and provided counsel and guidance to senior management and other leaders across the firm on a wide range of legal and regulatory matters. •Addressed legal and regulatory considerations applicable to our global investment advisory business and to our firm as a public company. •Led the fund formation legal team that provides the legal framework and guidance to our current and upcoming investment funds across our three global business segments. Led Firm Governance and Stewardship •Focused on risk management and the continuing enhancement of our global compliance function in light of complex and evolving regulatory requirements. •Managed the firm’s global litigation strategy and insurance program and oversaw several positive litigation outcomes in 2024. •Partnered with the Chief Financial Officer and Head of Corporate Strategy and Chief Operating Officer to realize operational improvement and efficiencies within the Legal and Compliance team. | |||||
![]() | Christopher Finn Senior Advisor and Former Chief Operating Officer | ||||
2024 Annual Performance Bonus: | $1,250,000 | ||||
Cash Portion: | $955,000 | ||||
RSU Deferral Portion: | $295,000 | ||||
Streamlined and Rightsized Operations •As Chief Operating Officer, implemented succession planning efforts to integrate Lindsay LoBue as our Deputy Chief Operating Officer and then led efforts to seamlessly onboard her as our new Chief Operating Officer with no interruption to our operations. •As Chief Operating Officer, conducted a strategic review of our businesses and then designed and implemented operational improvements to rightsize our personnel and operations and best deploy our talent and resources to meet key business needs in the business lines best poised for growth. Leveraged Extensive Experience to Advise European Corporate Private Equity Funds •As Senior Advisor, utilized his extensive prior experience with our Corporate Private Equity platform and service as Head of Europe over two decades prior to serving as Chief Operating Officer and advised our European funds on strategic initiatives, including by serving on the investment committees and advising fund leadership. Effective June 30, 2024, Mr. Finn retired from his role as Chief Operating Officer (and ceased serving as an executive officer) and transitioned to a role as Senior Advisor. Mr. Finn remains employed by the Company in this Senior Advisor role. | |||||
CARLYLE | Proxy Statement 2025 | 45 |
Compensation Matters |
46 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
Minimum Service Periods | ||||
1 year | 2 years | 3 years | ||
PSU Tranche 3 $64.06 (160% of starting share price) | ||||
PSU Tranche 2 $56.06 (140% of starting share price) | ||||
PSU Tranche 1 $48.05 (120% of starting share price) Target achieved: 11/6/24 Vested: 2/6/25 | ||||
Minimum Service Periods | ||||
1 year | 2 years | 3 years | ||
PSU Tranche 3 $65.01 (160% of starting share price) | ||||
PSU Tranche 2 $56.88 (140% of starting share price) | ||||
PSU Tranche 1 $48.76 (120% of starting share price) Target achieved: 11/8/24 Vested: 2/14/25 | ||||
CARLYLE | Proxy Statement 2025 | 47 |
Compensation Matters |
Minimum Service Periods | ||||
1 year | 2 years | 3 years | ||
PSU Tranche 3 $85.22 (160% of starting share price) | ||||
PSU Tranche 2 $74.56 (140% of starting share price) | ||||
PSU Tranche 1 $63.91 (120% of starting share price) | ||||
Name | Number of Time- Vesting RSUs | Number of 2023 Bonus Deferral RSUs | ||
John Redett | 429,800 | 8,955 | ||
Lindsay LoBue | — | 756 | ||
Jeffrey Ferguson | 107,450 | 6,268 | ||
Christopher Finn | 429,800 | 8,955 | ||
48 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
Grant Date | February 6, 2024 |
Terms | The annual time-vesting RSUs are eligible to vest 40% on August 1, 2025, 30% on August 1, 2026, and 30% on August 1, 2027, subject to the applicable named executive officer’s continued employment through each applicable vesting date. |
Grant Date | February 1, 2024 (for Ms. LoBue) and February 6, 2024 (for Messrs. Redett, Ferguson, and Finn) |
Terms | The 2023 Bonus Deferral RSUs are eligible to vest in equal installments of 1/3 on each of the first three anniversaries of the applicable grant date, subject to the applicable named executive officer’s continued employment through each applicable vesting date. |
Name | Number of Time- Vesting RSUs | |
John Redett | 257,412 | |
Lindsay LoBue | 79,887 | |
Jeffrey Ferguson | 62,134 | |
Grant Date | February 1, 2025 |
Terms | These time-vesting RSUs are eligible to vest 40% on August 1, 2026, 30% on August 1, 2027, and 30% on August 1, 2028, subject to the applicable named executive officer’s continued employment through each applicable vesting date. |
Goal | Performance Required | Earned | ||
Target (100% of Target Payout) | ||||
FRE | ![]() | Achieved |
CARLYLE | Proxy Statement 2025 | 49 |
Compensation Matters |
50 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
CARLYLE | Proxy Statement 2025 | 51 |
Compensation Matters |
52 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
Ownership Requirement (greater of) | |||
Value of Stock | Multiple of Annual Base Salary | ||
Chief Executive Officer | $10 million | N/A | |
Other Executive Officers | $2.5 million | 3x | |
CARLYLE | Proxy Statement 2025 | 53 |
Compensation Matters |
Anthony Welters (Chair) Lawton W. Fitt Mark S. Ordan Derica W. Rice |
54 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
Name and Principal Position | Year | Salary ($) | Cash Bonus ($) | Stock Awards ($)(1) | Non-Equity Incentive Plan Compensation ($) | All Other Compensation ($) | Total ($) | |||
Harvey M. Schwartz | 2024 | 1,000,000 | — | 22,513,410 | 6,000,000 | (2) | 76,766 | (3) | 29,590,176 | |
Chief Executive Officer (principal executive officer) | 2023 | 838,462 | — | 179,981,039 | 6,000,000 | 174,597 | 186,994,098 | |||
John C. Redett | 2024 | 500,000 | 2,005,000 | 30,945,622 | — | 210 | (4) | 33,450,832 | ||
Chief Financial Officer (principal financial officer) | 2023 | 500,000 | 2,250,000 | — | — | 79,346 | 2,829,346 | |||
Lindsay P. LoBue | 2024 | 500,000 | 2,405,000 | 3,300,559 | — | — | 6,205,559 | |||
Chief Operating Officer | ||||||||||
Jeffrey W. Ferguson | 2024 | 500,000 | 805,000 | 4,630,597 | — | 160,687 | (5) | 6,096,284 | ||
General Counsel | 2023 | 500,000 | 1,575,000 | 6,419,168 | — | 237,132 | 8,731,300 | |||
Christopher Finn | 2024 | 500,000 | 955,000 | 30,945,622 | — | 386,057 | (6) | 32,786,679 | ||
Senior Advisor and Former Chief Operating Officer | 2023 | 500,000 | 2,250,000 | 6,774,172 | — | 577,147 | 10,101,319 | |||
2022 | 500,000 | 1,750,000 | 3,108,697 | — | 1,168,413 | 6,527,110 |
CARLYLE | Proxy Statement 2025 | 55 |
Compensation Matters |
Estimated Future Payouts under Non- Equity Incentive Plan Awards | Estimated Future Payouts under Equity Incentive Plan Awards | All Other Stock Awards: Number of Shares of Stock (#) | Grant Date Fair Value of Stock and Option Awards ($) | ||||||||
Name | Grant Date | Threshold ($) | Target ($) | Maximum ($) | Threshold (#) | Target (#) | Maximum (#) | ||||
Harvey M. Schwartz | |||||||||||
CEO Performance Bonus(1) | $750,000 | $3,000,000 | $6,000,000 | ||||||||
Stock Price Appreciation Program PSUs (2) | 2/14/2024 | 243,784 | 731,351 | 731,351 | — | $22,513,410 | |||||
John C. Redett | |||||||||||
2024 Annual Time-Vesting RSUs(3) | 2/6/2024 | — | — | — | 429,800 | $17,501,456 | |||||
2023 Bonus Deferral RSUs(4) | 2/6/2024 | — | — | — | 8,955 | $364,648 | |||||
Stock Price Appreciation Program PSUs(5) | 2/6/2024 | 167,001 | 501,003 | 501,003 | — | $13,079,518 | |||||
Lindsay P. LoBue | |||||||||||
2023 Bonus Deferral RSUs(4) | 2/1/2024 | — | — | — | 756 | $30,678 | |||||
Stock Price Appreciation Program PSUs(5) | 2/6/2024 | 41,751 | 125,251 | 125,251 | — | $3,269,881 | |||||
Jeffrey W. Ferguson | |||||||||||
2024 Annual Time-Vesting RSUs(3) | 2/6/2024 | — | — | — | 107,450 | $4,375,364 | |||||
2023 Bonus Deferral RSUs(4) | 2/6/2024 | — | — | — | 6,268 | $255,233 | |||||
Christopher Finn | |||||||||||
2024 Annual Time-Vesting RSUs(3) | 2/6/2024 | — | — | — | 429,800 | $17,501,456 | |||||
2023 Bonus Deferral RSUs(4) | 2/6/2024 | — | — | — | 8,955 | $364,648 | |||||
Stock Price Appreciation Program PSUs(5) | 2/6/2024 | 167,001 | 501,003 | 501,003 | — | $13,079,518 | |||||
56 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
CARLYLE | Proxy Statement 2025 | 57 |
Compensation Matters |
58 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
Stock Awards | |||||||||
Number of Shares or Units of Stock That Have Not Vested (#) | Market Value of Shares or Units of Stock That Have Not Vested ($) | Number of Equity Incentive Shares or Units of Stock That Have Not Vested (#) | Market Value of Equity Incentive Shares or Units of Stock That Have Not Vested ($) | ||||||
Harvey M. Schwartz | 2,356,906 | (1) | $119,000,184 | 3,544,681 | (6) | $178,970,944 | |||
John C. Redett | 615,971 | (2) | $31,100,376 | 334,002 | (7) | $16,863,761 | |||
Lindsay P. LoBue | 42,521 | (3) | $2,146,886 | 83,501 | (8) | $4,215,966 | |||
Jeffrey W. Ferguson | 278,802 | (4) | $14,076,713 | — | $— | ||||
Christopher Finn | 802,316 | (5) | $40,508,935 | 334,002 | (7) | $16,863,761 | |||
CARLYLE | Proxy Statement 2025 | 59 |
Compensation Matters |
Stock Awards | |||
Number of Shares Acquired on Vesting (#) | Value Realized on Vesting ($)(6) | ||
Harvey M. Schwartz(1) | 1,542,890 | $69,661,829 | |
John C. Redett | — | $— | |
Lindsay P. LoBue | — | $— | |
Jeffrey W. Ferguson(2) | 129,274 | $5,806,395 | |
Christopher Finn(3) | 168,471 | $7,457,636 | |
60 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
CARLYLE | Proxy Statement 2025 | 61 |
Compensation Matters |
62 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
CARLYLE | Proxy Statement 2025 | 63 |
Compensation Matters |
64 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
CARLYLE | Proxy Statement 2025 | 65 |
Compensation Matters |
66 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
Plan category | Number of securities to be issued upon exercise of outstanding options, warrants and rights | Weighted- average exercise price of outstanding options, warrants and rights | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column)(3) | |
Equity compensation plans approved by security holders | 26,152,352 | (1) | — | 30,091,970 |
Equity compensation plans not approved by security holders | 5,170,236 | (2) | — | — |
Total | 31,322,588 | — | 30,091,970 |
CARLYLE | Proxy Statement 2025 | 67 |
Compensation Matters |
Summary Compensation Table Total for: | Compensation Actually Paid to: | Average Summary Compensation Table Total for Non-PEO Named Executive Officers(1),(2) | Average Compensation Actually Paid to Non-PEO Named Executive Officers(1),(2) | Value of Initial Fixed $100 Investment Based on: | Net Income (in millions) | Fee Related Earnings (FRE) (in millions)(4) | |||||||||||||||||
Year | Harvey M. Schwartz | William E. Conway, Jr. | Kewsong Lee | Glenn A. Youngkin | Harvey M. Schwartz(2) | William E. Conway, Jr.(2) | Kewsong Lee(2) | Glenn A. Youngkin(2) | Total Shareholder Return | Peer Group Total Shareholder Return(3) | |||||||||||||
2024 | $ | $— | $— | $— | $ | $— | $— | $— | $ | $ | $ | $ | $ | $ | |||||||||
2023 | $ | $ | $— | $— | $ | $ | $— | $— | $ | $ | $ | $ | $( | $ | |||||||||
2022 | $— | $ | $ | $— | $— | $ | $( | $— | $ | $ | $ | $ | $ | $ | |||||||||
2021 | $— | $— | $ | $— | $— | $— | $ | $— | $ | $ | $ | $ | $ | $ | |||||||||
2020 | $— | $— | $ | $ | $— | $— | $ | $( | $ | $ | $ | $ | $ | $ | |||||||||
Summary Compensation Total | Deductions of Reported Equity Values from Summary Compensation Total(a) | Equity Award Adjustments to Summary Compensation Total(b) | “Compensation Actually Paid” | |||||
Harvey M. Schwartz | ||||||||
2024 | $ | $( | $ | $ | ||||
Average of Non-PEO Named Executive Officers | ||||||||
2024 | $ | $( | $ | $ | ||||
68 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
Year End Fair Value of Awards Granted During Year that Remained Outstanding and Unvested at Year End | Year Over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in a Prior Year that Remained Outstanding and Unvested at Year End | Fair Value as of Vesting Date of Equity Awards Granted and Vested in Same Year | Change in Fair Value from Prior Year End to Vesting Date for Equity Awards Granted in a Prior Year that Vested in the Year | Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions During Year | Total Equity Award Adjustments | |||||||
Harvey M. Schwartz | ||||||||||||
2024 | $ | $ | $ | $ | $ | $ | ||||||
Average of Non-PEO Named Executive Officers | ||||||||||||
2024 | $ | $ | $ | $ | $ | $ | ||||||
CARLYLE | Proxy Statement 2025 | 69 |
Compensation Matters |

n | Harvey M. Schwartz |
n | Kewsong Lee |
n | Glenn A. Youngkin |
n | William E. Conway, Jr. |
n | Non-PEO NEOs |
![]() | Company TSR |
![]() | Peer Group TSR |

n | Harvey M. Schwartz |
n | Kewsong Lee |
n | Glenn A. Youngkin |
n | William E. Conway, Jr. |
n | Non-PEO NEOs |
![]() | Net Income |
70 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |

n | Harvey M. Schwartz |
n | Kewsong Lee |
n | Glenn A. Youngkin |
n | William E. Conway, Jr. |
n | Non-PEO NEOs |
![]() | FRE |
All information provided above under the “Pay Versus Performance” heading will not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent the Company specifically incorporates such information by reference. |
CARLYLE | Proxy Statement 2025 | 71 |
Compensation Matters |
Annual Retainers | 2024 Annual Rate | |
Cash-Based Portion of Annual Retainer | $140,000 | |
RSU-Based Portion of Annual Retainer | $205,000 | |
Additional Annual Cash Retainer for Lead Independent Director | $65,000 | |
Additional Annual Cash Retainer for Chairperson of Audit Committee | $40,000 | |
Additional Annual Cash Retainer for Chairperson of Compensation Committee | $25,000 | |
Additional Annual Cash Retainer for Chairperson of Nominating and Corporate Governance Committee | $25,000 | |
72 | CARLYLE | Proxy Statement 2025 |
Compensation Matters |
Name | Fees Earned or Paid in Cash | Stock Awards(1) | Total | |||
Afsaneh Beschloss(2) | $93,334 | $198,859 | $292,193 | |||
Sharda Cherwoo | $140,000 | $198,859 | $338,859 | |||
Linda H. Filler | $140,000 | $198,859 | $338,859 | |||
Lawton W. Fitt | $230,000 | $198,859 | $428,859 | |||
James H. Hance, Jr.(3) | $— | $— | $— | |||
Mark S. Ordan | $140,000 | $198,859 | $338,859 | |||
Derica W. Rice | $140,000 | $198,859 | $338,859 | |||
Dr. Thomas S. Robertson(4) | $58,334 | $— | $58,334 | |||
William J. Shaw | $180,000 | $198,859 | $378,859 | |||
Anthony Welters | $165,000 | $198,859 | $363,859 | |||
Stock Awards | |||
Name | Number of Shares or Units of Stock That Have Not Vested | Market Value of Shares or Units of Stock That Have Not Vested(1) | |
Afsaneh Beschloss | 5,004 | $252,652 | |
Sharda Cherwoo | 5,004 | $252,652 | |
Linda H. Filler | 5,004 | $252,652 | |
Lawton W. Fitt | 5,004 | $252,652 | |
Mark S. Ordan | 5,004 | $252,652 | |
Derica W. Rice | 5,004 | $252,652 | |
Dr. Thomas S. Robertson(2) | — | $— | |
William J. Shaw | 5,004 | $252,652 | |
Anthony Welters | 5,004 | $252,652 | |
CARLYLE | Proxy Statement 2025 | 73 |
74 | CARLYLE | Proxy Statement 2025 |
Certain Relationships and Related Transactions |
CARLYLE | Proxy Statement 2025 | 75 |
Certain Relationships and Related Transactions |
76 | CARLYLE | Proxy Statement 2025 |
Common Stock Beneficially Owned | ||
Name of Beneficial Owner | Number | % of Class |
The Vanguard Group(1) | 24,876,188 | 6.9% |
BlackRock Inc.(2) | 21,846,507 | 6.1% |
Capital World Investors(3) | 20,008,088 | 5.5% |
Harvey M. Schwartz | 1,489,265 | * |
John C. Redett | 120,905 | * |
William E. Conway, Jr. | 29,999,644 | 8.3% |
David M. Rubenstein(4) | 29,249,644 | 8.1% |
Daniel A. D’Aniello | 32,504,102 | 9.0% |
Jeffrey W. Ferguson | 814,731 | * |
Christopher Finn(5) | 245,685 | * |
Lindsay P. LoBue | 18,775 | * |
Afsaneh Beschloss(6) | 5,004 | * |
Sharda Cherwoo(6) | 10,713 | * |
Linda H. Filler(6) | 16,478 | * |
Lawton W. Fitt(6) | 68,408 | * |
James H. Hance, Jr.(6) | 306,853 | * |
Mark S. Ordan(6) | 16,478 | * |
Derica W. Rice(5), (6) | 24,656 | * |
William J. Shaw(6) | 68,408 | * |
Anthony Welters(6) | 51,070 | * |
All executive officers and directors as a group (16 persons)(6) | 94,765,134 | 26.3% |
CARLYLE | Proxy Statement 2025 | 77 |
78 | CARLYLE | Proxy Statement 2025 |
When and where is our Annual Meeting? | We will be holding our Annual Meeting virtually, on Thursday, May 29, 2025, at 9:00 a.m. EDT, via the Internet at www.virtualshareholdermeeting.com/CG2025. The virtual meeting format for the Annual Meeting enables full and equal participation by all of our shareholders from any place in the world at little to no cost. We designed the format of the virtual Annual Meeting to ensure that shareholders who attend our Annual Meeting will be afforded the same rights and opportunities to participate as they would at an in-person meeting. At our virtual Annual Meeting, shareholders will be able to attend, vote, and submit questions via the Internet. Whether or not you plan to attend the Annual Meeting, we urge you to vote and submit your proxy in advance of the meeting by one of the methods described in these proxy materials. Additional information can be found at www.proxyvote.com. |
How can I attend our Annual Meeting? | Shareholders as of the record date may attend, vote, and submit questions virtually at our Annual Meeting by logging in approximately fifteen minutes before 9:00 a.m. EDT. To log in, shareholders (or their authorized representatives) will need the control number provided on their proxy card, voting instruction form, or Notice. If you are not a shareholder or do not have a control number, you will not be able to participate. The availability of online voting may depend on the voting procedures of the organization that holds your shares. |
Can I ask questions at the virtual Annual Meeting? | Shareholders as of our record date who attend and participate in our virtual Annual Meeting at 9:00 a.m. EDT will have an opportunity to submit questions live via the Internet during a designated portion of the meeting. Shareholders must have available their control number provided on their proxy card, voting instruction form, or Notice. Questions submitted in accordance with the meeting rules of conduct will be answered during the meeting, subject to time constraints. Questions regarding claims or personal matters, including those related to employment issues, are not pertinent to meeting matters and therefore will not be answered. |
What if during the check-in time or during the meeting I have technical difficulties or trouble accessing the virtual meeting website? | We will have technicians ready to assist you with any technical difficulties you may have accessing the virtual meeting. If you encounter any difficulties accessing the virtual meeting during check-in or the meeting, please call the technical support number that will be posted on the virtual meeting platform log-in page. If there are any technical issues in convening or hosting the meeting, we will promptly post information to our website, including information on when the meeting will be reconvened. |
What is included in our proxy materials? | Our proxy materials, which are available at www.proxyvote.com, include: •Our Notice of 2025 Annual Meeting of Shareholders, •Our Proxy Statement, and •Our 2024 Annual Report to Shareholders. If you received printed versions of these materials by mail (rather than through electronic delivery), these materials also included a proxy card or voting instruction form. |
CARLYLE | Proxy Statement 2025 | 79 |
Frequently Asked Questions |
How are we distributing our proxy materials? | To expedite delivery, reduce our costs, and decrease the environmental impact of our proxy materials, we used “Notice and Access” in accordance with an SEC rule that permits us to provide proxy materials to our shareholders over the Internet. On or about April 17, 2025, we will send a Notice of Internet Availability of Proxy Materials to certain of our shareholders containing instructions on how to access our proxy materials online. If you received a Notice, you will not receive a printed copy of the proxy materials in the mail. Instead, the Notice instructs you on how to access and review all of the important information contained in the proxy materials. The Notice also instructs you on how you may submit your proxy via the Internet. If you received a Notice and would like to receive a copy of our proxy materials, follow the instructions contained in the Notice to request a copy electronically or in paper form on a one-time or ongoing basis. |
Who can vote at our Annual Meeting? | You can vote your shares of common stock at our Annual Meeting if you were a shareholder at the close of business on April 4, 2025. As of April 4, 2025, there were 360,881,683 shares of common stock outstanding, each of which entitles the holder to one vote for each matter to be voted on at our Annual Meeting. |
What is the difference between holding shares as a shareholder of record and as a beneficial owner of shares held in street name? | Shareholder of Record. If your shares of common stock are registered directly in your name with our transfer agent, Equiniti Trust Company, you are considered a “shareholder of record” of those shares. You may contact our transfer agent (by regular mail or phone) at: Equiniti Trust Company Operations Center 6201 15th Avenue Brooklyn, NY 11219 Phone: (800) 937-5449 Beneficial Owner of Shares Held in Street Name. If your shares are held in an account at a bank, brokerage firm, broker-dealer, or other similar organization, then you are a beneficial owner of shares held in street name. In that case, you will have received these proxy materials from the bank, brokerage firm, broker-dealer, or other similar organization holding your account and, as a beneficial owner, you have the right to direct your bank, brokerage firm, or similar organization as to how to vote the shares held in your account. |
How do I vote? | To be valid, your vote by Internet, telephone, or mail must be received by the deadline specified on the proxy card or voting information form, as applicable. Whether or not you plan to attend the Annual Meeting, we urge you to vote and submit your proxy in advance of the meeting. |
80 | CARLYLE | Proxy Statement 2025 |
Frequently Asked Questions |
Can I change my vote after I have voted? | You can revoke your proxy at any time before it is voted at our Annual Meeting, subject to the voting deadlines that are described on the proxy card or voting instruction form, as applicable. You can revoke your vote: •By voting again by Internet or by telephone (only your last Internet or telephone proxy submitted prior to the meeting will be counted), •By signing and returning a new proxy card with a later date, •By obtaining a “legal proxy” from your account representative at the bank, brokerage firm, broker- dealer, or other similar organization through which you hold shares, or •By voting at the Annual Meeting. You may also revoke your proxy by giving written notice of revocation to the Corporate Secretary at The Carlyle Group Inc., 1001 Pennsylvania Avenue, NW, Washington, DC 20004, which must be received no later than 5:00 p.m., Eastern Time, on May 28, 2025. If you intend to revoke your proxy by providing such written notice, we advise that you also send a copy via email to publicinvestor@carlyle.com. If your shares are held in street name, we also recommend that you contact your broker, bank, or other nominee for instructions on how to change or revoke your vote. |
How can I obtain an additional proxy card? | Shareholders of record can contact our Investor Relations team at The Carlyle Group Inc., 1001 Pennsylvania Avenue, NW, Washington, DC 20004, Attention: Investor Relations, telephone: (202) 729-5800, email: publicinvestor@carlyle.com. If you hold your shares of common stock in street name, contact your account representative at the bank, brokerage firm, broker-dealer, or other similar organization through which you hold your shares. |
How will my shares be voted if I do not vote at the Annual Meeting? | The proxy holders (that is, the persons named as proxies on the proxy card) will vote your shares of common stock in accordance with your instructions at the Annual Meeting (including any adjournments or postponements thereof). |
How will my shares be voted if I do not give specific voting instructions? | Shareholders of Record. If you indicate that you wish to vote as recommended by our Board or if you sign, date, and return a proxy card but do not give specific voting instructions, then the proxy holders will vote your shares in the manner recommended by our Board on all matters presented in this Proxy Statement, and the proxy holders may determine in their discretion regarding any other matters properly presented for a vote at our Annual Meeting. Although our Board does not anticipate that any of the director nominees will be unable to stand for election as a director nominee at our Annual Meeting, if this occurs, proxies will be voted in favor of such other person or persons as may be recommended by our Nominating and Corporate Governance Committee and designated by our Board. Beneficial Owners of Shares Held in Street Name. If your bank, brokerage firm, broker- dealer, or other similar organization does not receive specific voting instructions from you, how your shares may be voted will depend on the type of proposal. •Ratification of Ernst & Young LLP as our Independent Registered Public Accounting Firm for 2025 (Item 2). NYSE rules allow your bank, brokerage firm, broker-dealer, or other similar organization to vote your shares only on routine matters. Proposal 2, the ratification of Ernst & Young as our independent registered public accounting firm for 2025, is the only matter for consideration at the meeting that NYSE rules deem to be routine. •All Other Matters (Items 1 and 3). All other proposals are non-routine matters under Nasdaq rules, which means your bank, brokerage firm, broker-dealer, or other similar organization may not vote your shares without voting instructions from you. Therefore, you must give your broker instructions in order for your vote to be counted. |
CARLYLE | Proxy Statement 2025 | 81 |
Frequently Asked Questions |
What is a Broker Non-Vote? | A “broker non-vote” occurs when your broker submits a proxy for the meeting with respect to the ratification of the appointment of independent registered public accounting firm but does not vote on non-discretionary matters because you did not provide voting instructions on these matters. |
What is the quorum requirement for our Annual Meeting? | A quorum is required to transact business at our Annual Meeting. With respect to the election of directors, the holders of our outstanding shares of common stock entitled to vote as of April 4, 2025 who attend the Annual Meeting, provided that such holders represent at least one-third of our outstanding shares of common stock, represented either in person or by proxy, will constitute a quorum. With respect to the other matters to be voted on at the Annual Meeting, the holders of a majority of the outstanding shares of common stock entitled to vote as of April 4, 2025, represented in person or by proxy, will constitute a quorum. Abstentions, withhold votes, and shares represented by broker non-votes will be treated as present for quorum purposes. Virtual attendance at our Annual Meeting constitutes presence in person for purposes of quorum at the meeting. |
Who counts the votes cast at our Annual Meeting? | Representatives of Broadridge will tabulate the votes cast at our Annual Meeting, and Christopher Woods will act as the independent inspector of election. |
Where can I find the voting results of our Annual Meeting? | We expect to announce the preliminary voting results at our Annual Meeting. The final voting results will be reported in a Current Report on Form 8-K filed with the SEC and posted on our website. |
When will Carlyle hold an advisory vote on the frequency of Say-on-Pay votes? | The next advisory vote on the frequency of Say-on-Pay votes will be held no later than our 2027 Annual Meeting of Shareholders. |
How do I obtain more information about Carlyle? | A copy of our 2024 Annual Report to Shareholders accompanies this Proxy Statement. You also may obtain, free of charge, a copy of that document, our 2024 Annual Report on Form 10-K, including our financial statements and schedules thereto, our Governance Policy, our Code of Conduct, our Code of Ethics for Financial Professionals, and Audit Committee charter by writing to: The Carlyle Group Inc., 1001 Pennsylvania Avenue, NW, Washington, DC 20004, Attn: Investor Relations, telephone: (202) 729-5800, email: publicinvestor@carlyle.com. These documents, as well as other information about The Carlyle Group Inc., are also available on our website at ir.carlyle.com/governance. |
How do I inspect the list of shareholders of record? | A list of the shareholders of record as of April 4, 2025 will be available for inspection during ordinary business hours at our headquarters at The Carlyle Group Inc., 1001 Pennsylvania Avenue, NW, Washington, DC 20004, for a period of 10 days prior to the Annual Meeting. |
How do I sign up for electronic delivery of proxy materials? | This Proxy Statement and our 2024 Annual Report to Shareholders are available at: www.proxyvote.com. If you would like to help reduce our costs of printing and mailing future materials, you can agree to access these documents in the future over the Internet rather than receiving printed copies in the mail. For your convenience, you may find links to sign up for electronic delivery for both shareholders of record and beneficial owners who hold shares in street name at www.proxyvote.com. Once you sign up, you will continue to receive proxy materials electronically until you revoke this preference. |
82 | CARLYLE | Proxy Statement 2025 |
Frequently Asked Questions |
Who pays the expenses of this proxy solicitation? | Our proxy materials are being used by our Board in connection with the solicitation of proxies for our Annual Meeting. We pay the expenses of the preparation of proxy materials and the solicitation of proxies for our Annual Meeting. In addition to the solicitation of proxies by mail, certain of our directors, officers, or employees may solicit telephonically, electronically, or by other means of communication. Our directors, officers, and employees will receive no additional compensation for any such solicitation. |
What is “householding?” | In accordance with a notice sent to certain street name shareholders of common stock who share a single address, shareholders at a single address will receive only one copy of this Proxy Statement and our 2024 Annual Report to Shareholders unless we have previously received contrary instructions. This practice, known as “householding,” is designed to reduce our printing and postage costs. We currently do not “household” for shareholders of record. If your household received a single set of proxy materials, but you would prefer to receive a separate copy of this Proxy Statement or our 2024 Annual Report to Shareholders, you may contact us at The Carlyle Group Inc., 1001 Pennsylvania Avenue, NW, Washington, DC 20004, Attn: Investor Relations, telephone: (202) 729-5800, email: publicinvestor@carlyle.com, and we will deliver those documents to you promptly upon receiving the request. You may request or discontinue householding in the future by contacting the broker, bank or similar institution through which you hold your shares. You may also change your householding preferences you may contact Broadridge, either by calling (866) 540-7095, or by writing to Broadridge, Householding Department, 51 Mercedes Way, Edgewood, New York, 11717. Shareholders also must satisfy the notification, timeliness, consent, and information requirements set forth in our amended and restated certification of incorporation. |
How can I submit a Rule 14a-8 shareholder proposal at the 2026 Annual Meeting of Shareholders? | Shareholders who, in accordance with the SEC’s Rule 14a-8, wish to present proposals for inclusion in the proxy materials to be distributed by us in connection with our 2026 Annual Meeting of Shareholders must submit their proposals to the Corporate Secretary by mail at The Carlyle Group, 1001 Pennsylvania Avenue, NW, Washington, DC 20004. Proposals must be received on or before December 18, 2025. As the rules of the SEC make clear, however, simply submitting a proposal does not guarantee its inclusion. |
How can I submit nominees or shareholder proposals in accordance with our amended and restated certificate of incorporation? | In accordance with our amended and restated certificate of incorporation, in order to properly bring director nominations or any other business, including shareholder proposals to be included in our proxy materials, before the 2026 Annual Meeting of Shareholders, a shareholder’s notice of the matter that the shareholder wishes to present must be delivered to the Corporate Secretary by mail at The Carlyle Group, 1001 Pennsylvania Avenue, NW, Washington, DC 20004, in compliance with the procedures and along with the other information required by our amended and restated certificate of incorporation, not later than the close of business on the 90th day nor earlier than the close of business on the 120th day prior to the first anniversary of the 2025 Annual Meeting. As a result, any notice given by or on behalf of a shareholder pursuant to these provisions of our amended and restated certificate of incorporation must be received no earlier than January 29, 2026 and no later than February 28, 2026. In the event that the 2026 Annual Meeting of Shareholders is held more than 30 days before or more than 70 days after May 29, 2026, notice by the shareholder must be received no earlier than the 120th day prior to such annual meeting and no later than the close of business on the later of the 90th day prior to such annual meeting or the 10th day following the day on which public announcement of the date of the annual meeting is first made. In addition to satisfying the foregoing requirements under our amended and restated certificate of incorporation, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than our Board’s nominees must provide notice that sets forth any additional information required by Rule 14a-19 under the Exchange Act no later than March 30, 2026. |
CARLYLE | Proxy Statement 2025 | 83 |
Frequently Asked Questions |
Proposal | Required Vote | Board Recommendation |
Item 1. Election of Directors Named in this Proxy Statement | A plurality of the votes cast (for each director nominee) | FOR all nominees Unless a contrary choice is specified, proxies solicited by our Board will be voted FOR the election of the director nominees |
Item 2. Ratification of Ernst & Young LLP as our Independent Registered Public Accounting Firm for 2025 | A majority of the votes cast | FOR the ratification of the appointment of Ernst & Young Unless a contrary choice is specified, proxies solicited by our Board will be voted FOR the ratification of the appointment |
Item 3. Non-Binding Vote to Approve Named Executive Officer Compensation (“Say-on-Pay”) | A majority of the votes cast | FOR the approval of the compensation of our named executive officers Unless a contrary choice is specified, proxies solicited by our Board will be voted FOR the resolution |
Proposal | Voting Options | Effect of Abstentions or Withhold Votes, as Applicable | Broker Discretionary Voting Allowed? | Effect of Broker Non-Votes |
Item 1. Election of Directors Named in this Proxy Statement | FOR or WITHHOLD (for each director nominee). | No effect — will be excluded entirely from the vote with respect to the nominee from which they are withheld | No | No effect |
Item 2. Ratification of Ernst & Young LLP as our Independent Registered Public Accounting Firm for 2025 | FOR, AGAINST, or ABSTAIN | No effect — not counted as a “vote cast” | Yes | N/A |
Item 3. Non-Binding Vote to Approve Named Executive Officer Compensation (“Say-on-Pay”) | FOR, AGAINST, or ABSTAIN | No effect — not counted as a “vote cast” | No | No effect |
CARLYLE | Proxy Statement 2025 | A-1 |
For the Year Ended December 31, 2024 | |||||||||
(in millions) | Total Reportable Segments | Consolidated Funds | Reconciling Items | Carlyle Consolidated | |||||
Revenues | $3,655.4 | $631.6 | $1,138.8 | (a) | $5,425.8 | ||||
Expenses | $2,129.9 | $610.3 | $1,315.9 | (b) | $4,056.1 | ||||
Other income | $— | $24.0 | $— | (c) | $24.0 | ||||
Distributable earnings | $1,525.5 | $45.3 | $(177.1) | (d) | $1,393.7 | ||||
For the Year Ended December 31, 2023 | |||||||||
(in millions) | Total Reportable Segments | Consolidated Funds | Reconciling Items | Carlyle Consolidated | |||||
Revenues | $3,405.1 | $570.1 | $(1,011.3) | (a) | $2,963.9 | ||||
Expenses | $1,974.6 | $460.3 | $1,136.8 | (b) | $3,571.7 | ||||
Other income | $— | $6.9 | $— | (c) | $6.9 | ||||
Distributable earnings | $1,430.5 | $116.7 | $(2,148.1) | (d) | $(600.9) | ||||
Year Ended December 31, | ||||
(in millions) | 2024 | 2023 | ||
Unrealized performance and fee related performance revenues | $1,031.9 | $(1,046.6) | ||
Unrealized principal investment income | 34.1 | 36.1 | ||
Principal investment loss from dilution of indirect investment in Fortitude | — | (104.0) | ||
Adjustments related to expenses associated with investments in NGP Management and its affiliates | (13.1) | (13.8) | ||
Non-controlling interests and other adjustments to present certain costs on a net basis | 167.9 | 191.6 | ||
Elimination of revenues of Consolidated Funds | (82.0) | (74.6) | ||
$1,138.8 | $(1,011.3) | |||
A-2 | CARLYLE | Proxy Statement 2025 |
Appendix A: Reconciliations of Non-GAAP Measures |
Year Ended December 31, | ||||
(in millions) | 2024 | 2023 | ||
Total Reportable Segments - Fund level fee revenues | $2,403.8 | $2,305.8 | ||
Adjustments(1) | (215.7) | (262.6) | ||
Carlyle Consolidated - Fund management fees | $2,188.1 | $2,043.2 | ||
Year Ended December 31, | ||||
(in millions) | 2024 | 2023 | ||
Unrealized performance and fee related performance revenue compensation expense | $635.2 | $612.6 | ||
Equity-based compensation | 476.5 | 260.1 | ||
Acquisition or disposition-related charges and amortization of intangibles and impairment | 136.6 | 145.3 | ||
Tax expense associated with certain foreign performance revenues related compensation | (1.0) | (1.0) | ||
Non-controlling interests and other adjustments to present certain costs on a net basis | 92.8 | 148.7 | ||
Other adjustments | 21.2 | 11.6 | ||
Elimination of expenses of Consolidated Funds | (45.4) | (40.5) | ||
$1,315.9 | $1,136.8 | |||
Year Ended December 31, | ||||
(in millions, except per share amounts) | 2024 | 2023 | ||
Income (loss) before provision for income taxes | $1,393.7 | $(600.9) | ||
Adjustments: | ||||
Net unrealized performance and fee related performance revenues | (396.7) | 1,659.2 | ||
Unrealized principal investment income | (34.1) | (36.1) | ||
Principal investment loss from dilution of indirect investment in Fortitude | — | 104.0 | ||
Equity-based compensation(1) | 476.5 | 260.1 | ||
Acquisition or disposition-related charges, including amortization of intangibles and impairment | 136.6 | 145.3 | ||
Net income attributable to non-controlling interests in consolidated entities | (70.7) | (111.7) | ||
Tax expense associated with certain foreign performance revenues | (1.0) | (1.0) | ||
Other adjustments(2) | 21.2 | 11.6 | ||
Distributable Earnings | $1,525.5 | $1,430.5 | ||
Realized performance revenues, net of related compensation(3) | 366.1 | 531.0 | ||
Realized principal investment income(3) | 101.0 | 88.8 | ||
Net interest | 46.2 | 48.7 | ||
Fee Related Earnings | $1,104.6 | $859.4 | ||
Distributable Earnings | $1,525.5 | $1,430.5 | ||
Less: Estimated current corporate, foreign, state and local taxes(4) | 210.3 | 255.4 | ||
Distributable Earnings, net | $1,315.2 | $1,175.1 | ||
Distributable Earnings, net per common share outstanding(5) | $3.66 | $3.24 | ||
FRE margin(6) | 46% | 37% | ||
Margin on income (loss) before provision for income taxes(7) | 26% | (20%) | ||
CARLYLE | Proxy Statement 2025 | A-3 |
Appendix A: Reconciliations of Non-GAAP Measures |
Year Ended December 31, 2024 | ||||||
(in millions) | Carlyle Consolidated | Adjustments | Total Reportable Segments | |||
Performance revenues | $2,015.7 | $(939.8) | $1,075.9 | |||
Performance revenues related compensation expense | 1,361.5 | (651.7) | 709.8 | |||
Net performance revenues | $654.2 | $(288.1) | $366.1 | |||
Principal investment income (loss) | $238.7 | $(137.7) | $101.0 | |||
Year Ended December 31, 2023 | ||||||
(in millions) | Carlyle Consolidated | Adjustments | Total Reportable Segments | |||
Performance revenues | $(88.6) | $1,026.9 | $938.3 | |||
Performance revenues related compensation expense | 1,103.7 | (696.4) | 407.3 | |||
Net performance revenues | $(1,192.3) | $1,723.3 | $531.0 | |||
Principal investment income (loss) | $133.4 | $(44.6) | $88.8 | |||
A-4 | CARLYLE | Proxy Statement 2025 |
Appendix A: Reconciliations of Non-GAAP Measures |
As of December 31, | ||||
(in millions) | 2024 | 2023 | ||
Accrued performance allocations, net of accrued giveback obligations(1) | $7,009.5 | $6,125.9 | ||
Plus: Accrued performance allocations from NGP Carry Funds(2) | 489.4 | 484.4 | ||
Less: Net accrued performance allocations presented as fee related performance revenues | — | (5.2) | ||
Less: Accrued performance allocation-related compensation | (4,788.5) | (4,235.5) | ||
Plus: Receivable for giveback obligations from current and former employees | 11.5 | 11.5 | ||
Less: Deferred taxes on certain foreign accrued performance allocations | (19.0) | (27.1) | ||
Plus/Less: Net accrued performance allocations/giveback obligations attributable to non-controlling interests in consolidated entities | 0.2 | 7.4 | ||
Plus: Net accrued performance allocations attributable to Consolidated Funds, eliminated in consolidation | 10.1 | 9.1 | ||
Net accrued performance revenues before timing differences | 2,713.2 | 2,370.5 | ||
Plus/Less: Timing differences between the period when accrued performance allocations/giveback obligations are realized and the period they are collected/distributed | 24.7 | 8.3 | ||
Net accrued performance revenues attributable to The Carlyle Group Inc. | $2,737.9 | $2,378.8 | ||
As of December 31, | ||||
(in millions) | 2024 | 2023 | ||
Investments, excluding performance allocations | $3,883.2 | $3,785.4 | ||
Less: Amounts attributable to non-controlling interests in consolidated entities | (309.6) | (173.9) | ||
Plus: Investments in Consolidated Funds, eliminated in consolidation | 377.3 | 140.1 | ||
Less: Strategic equity method investments in NGP Management(1) | (369.2) | (370.3) | ||
Less: Investment in NGP general partners-accrued performance allocations(1) | (489.4) | (484.4) | ||
Total investments attribution to The Carlyle Group Inc. | 3,092.3 | 2,896.9 | ||
Less: CLO loans and other borrowings collateralized by investments attributable to The Carlyle Group Inc.(2) | (271.6) | (408.8) | ||
Total investments attributable to The Carlyle Group Inc., net of CLO loans and other borrowings | $2,820.7 | $2,488.1 | ||


